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Examination of the prevalence of subclinical cardiovascular disease (SCD) may help us 
to delineate future trends of coronary heart disease (CHD) mortality. There are substantial 
differences in the prevalence of SCD in different population groups. Identification of explaining 
factors for the difference in SCD rates across different population groups can provide new 
preventive strategies for reducing CHD morbidity or mortality. Based on this, the EBCT and 
Risk Factor Assessment among Japanese and U.S. Men in the Post World War II Birth Cohort 
(ERA-JUMP) Study is an ongoing population-based-cross-sectional study to examine differences 
in SCD rates across Japanese, Japanese American, and U.S. white men, and Korean men aged 
40-49 years.  
As a part of the ERA-JUMP study, the present study demonstrated that: 1) among 
middle-aged men, Koreans in South Korea had a significantly higher level of carotid intima-
media thickness than the Japanese in Japan. Middle-aged Korean men may continue to be at 
more increased risk for CHD than Japanese men at least over the near future. 2) Of 
polyunsaturated fatty acids, the proportion of linoleic acid was significantly and inversely 
associated with unfavorable levels of lipoprotein subclasses in three population groups of 
Japanese, Japanese American, and white men; an inverse association of docoxahexaenoic acid 
occurred only in white men. 3) Associations between pulse wave velocity (PWV) and 
 iv
cardiovascular risk factors were segmental-specific among white men. Brachial-ankle PWV had 
a mixed characteristic of stiffness of the central and peripheral arteries, compared to carotid-
femoral PWV having a characteristic of the central arteries. 
Public health importance of these findings is that: First, we can provide scientific 
information imperative to addressing a health-related problem (i.e., increasing risk for 
cardiovascular disease in South Korea). Second, the promotion of enriched intakes of linoleic 
acid (e.g., sunflower, corn, safflower oils) and fish-derived n-3 fatty acids (e.g., mackerel or 
salmon) should be addressed to public in habitual diet in the prevention of CHD by establishing 
practical guidelines. Finally, incorporation of both measures of brachial-ankle PWV and carotid-
femoral PWV into the assessment of arterial stiffness should be considered when screening a 
high-risk group for cardiovascular disease. 
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1.0  INTRODUCTION 
1.1 SPECIFIC AIMS 
Cardiovascular disease (CVD) is the leading cause of mortality worldwide, responsible for one-
third of all deaths.1 There is considerable variation in coronary heart disease (CHD) mortality 
rates across countries.1, 2 CHD mortality rate in Japan is the lowest among developed countries, 
which has been decreasing since the 1970s.2, 3 Even among men in post World War II (WWII) 
birth cohort, who adopted a westernized lifestyle from childhood and young adulthood, the CHD 
mortality rate is much lower in Japan than Western countries (e.g., U.S.) as well as other Asian 
countries (e.g., South Korea).4  
Examination of the prevalence of subclinical cardiovascular disease (SCD) across 
countries may help us to identify explaining factors for the difference in the SCD rates. 
Especially, SCD rates in young and middle-aged population groups may reflect recent or future 
trends in CHD mortality. As a result, we can provide new preventive strategies for leveling off 
current trends of CHD morbidity or mortality. 
The EBCT and Risk Factor Assessment among Japanese and U.S. Men in the Post 
World War II Birth Cohort (ERA-JUMP) study is an ongoing, population-based, cross-sectional 
study of four population groups of healthy men (i.e., Japanese, Japanese American, Korean, and 
U.S. white men) aged 40 to 49 years. The ERA-JUMP study was primarily designed to 
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investigate differences in the prevalence of SCD rates (i.e., carotid intima-media thickness, 
coronary calcification, and pulse wave velocity) across the population groups. According to main 
findings of the ERA-JUMP study, Japanese in Japan had lower levels of carotid intima-media 
thickness and lower prevalence of coronary calcification than U.S. white men.5 Furthermore, a 
serum high level of marine-derived n-3 polyunsaturated fatty acids (PUFA) explained the lower 
level of carotid initma-media thickness and lower prevalence of coronary calcification in 
Japanese men in Japan than in U.S. white men.6 As a part of the ERA-JUMP study, we need, in 
the present study, to investigate the difference in SCD rates between two Asian population 
groups who have similar socio-cultural and genetic background. Second, we need to determine if 
n-3 or n-6 PUFA that are recognized as a protective factor against CHD is significantly 
associated with mediators for atherosclerosis. Third, we need to assess potential utility of 
brachial-ankle pulse wave velocity (PWV) for screening a high-risk group for CHD.      
This cross-sectional study as a part of the ERA-JUMP study has three specific aims: 
1) To determine if there is a significant difference in the levels of carotid intima-media 
thickness between 102 Korean and 250 Japanese men aged 40-49 years. 
2) To examine the relation between serum polyunsaturated fatty acids and atherogenic 
lipoprotein subclasses (e.g., large very low-density lipoprotein particles, small low-
density lipoprotein particles, and large high-density lipoprotein particles) in 285 
Japanese, 212 Japanese American and 261 white men.  
3) To examine segmental-specific associations between pulse wave velocity (e.g., 
carotid-femoral PWV and brachial-ankle PWV) and cardiovascular risk factors in 248 
white men. 
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1.2 BACKGROUND AND SIGNIFICANCE 
1.2.1 Variation in coronary heart disease mortality 
CVD is the leading cause of mortality worldwide, responsible for about one-third of all deaths 1. 
Among CVD, CHD is decreasing in many developed countries, but is increasing in developing 
and transitional countries, partly as a result of increasing longevity, urbanization, and lifestyle 
changes.1 However, even among developed countries, there is considerable variation in CHD 
mortality rates. A landmark international cardiovascular epidemiological study, called the Seven 
Countries Study, initiated to identify the variation in CHD mortality across seven countries 
including 16 cohorts (12,467 men aged 40-59 years). Age-standardized 25-year mortality from 
CHD in the population from Northern Europe was the highest (100/10,000 person-years), 
followed by the population from the United States (73/10,000 person-years), whereas that from 
Japan was the lowest (17/10,000 person-years).2 
Modern epidemiological studies have made attempts to explain reasons for the variation 
in CHD rates. Potential reasons for such variation include differing stages of epidemiologic 
transition in various countries, varying environmental effects due to dissimilar burden of CVD 
risk factors, inherent genetic differences, and distinct early childhood programming influences. 
As an environmental reason, the Seven Countries Study supported a diet-heart hypothesis 
through the ecological correlations of cholesterol intake to rates of CHD mortality.7 A 20 mg/dl 
increase in total cholesterol corresponded to an increase in CHD mortality risk of 12%.7 Across 
the countries, a level of cholesterol was linearly correlated to CHD mortality; a relative increase 
in CHD mortality rates with a given cholesterol increase was the same across those countries. 
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CHD mortality rates in Japan have been decreasing since the 1970s.3 Even among men in 
post World War II (WWII) birth cohort, who adopted a westernized lifestyle from childhood and 
young adulthood, CHD mortality rate is much lower in Japan than in other developed countries 
including the United States (U.S.).8 Therefore, we need to explore the reasons for the low CHD 
rates in Japan, beyond cholesterol intake, to provide a new strategy for reducing CHD mortality 
rates worldwide.  
The Westernization of Japanese diet has resulted in a gradual increase in the intakes of 
total fat and animal fat since the 1960s.3, 9 In Japan, cancer mortality rates associated with high 
fat intake (e.g., colon, prostate, and breast cancer) are likely to parallel the increased tends of fat 
intake from National Nutritional Survey in Japan.3 However, the low CHD mortality in Japan has 
not paralleled the gradually-increased level of total cholesterol with the westernized diet. It may 
not be due to genetic susceptibility of the Japanese people, because CHD mortality in Japanese 
migrants to the U.S. increased.10 A careful investigation demonstrated that the low CHD 
mortality in Japan did not result from the misclassification of cause of death.11 Moreover, it is 
unlikely due to some lifestyle specific to Asian populations because CHD mortality in China 
increased as many other Asian countries. The World Health Organization MONICA study 
reported that CHD mortality in Beijing, China increased during 1984-1999, which was explained 
by the increased total cholesterol.12 Furthermore, there is no evidence that the strength and nature 
of associations between CHD risk factors and CHD mortality are different between Asians and 
Caucasians. The Asia Pacific Cohort Studies Collaboration (APCSC) group demonstrated that 
hazard ratios for CHD mortality associated with risk factors were similar between Asians and 
Caucasians, including systolic blood pressure, total cholesterol, smoking, and diabetes (Figure 
1).13 In this regard, we assume that relative risks for CHD mortality associated with the risk 
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factors may be similar between the Japanese and Caucasians, because 42% of deaths caused by 
CHD were from the Japanese cohort of entire Asian cohorts in the APCSC study.  
 
 
Figure 1 Relative risks of coronary heart disease mortality associated with risk factors (Asia Pacific 
Cohort Studies Collaboration group, 2005)  
TC=total cholesterol 
 
Most of the basis on prevention and treatment derives from studies conducted in white 
populations. The prevention and treatment strategies such as use of lipid-lowering medications 
(e.g., statins), hypertensive medications (e.g., angiotensin-converting enzyme inhibitors), or 
aspirin, can be applied to other ethnic populations.14 However, there is still a need to identify the 
reasons for the lower CHD mortality rates in Japan so that we can find out some other risk 
factors for CHD than determined in the white populations. Based on this effort, we may provide 
a new preventive strategy for controlling newer risk factors for CHD in cardiovascular 
prevention. 
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1.2.2 ERA-JUMP study: Low rates in subclinical cardiovascular diseases in the Japanese 
than in Whites and Japanese Americans 
The ERA-JUMP study, a population-based-cross-sectional study, investigated variation in rates 
of subclinical cardiovascular disease (SCD) across Japanese, Japanese American, and U.S. men 
aged 40 to 49 years of the post World-War-II birth cohort. The ERA-JUMP study examined 
three markers of SCD: 1) levels of carotid intima-media thickness (IMT), 2) prevalence of 
coronary calcification, and 3) levels of arterial stiffness measured by pulse wave velocity. The 
study participants of the ERA-JUMP study were randomly recruited: 313 Japanese from Kusatsu 
in Japan, 303 Japanese Americans from Honolulu, Hawaii, U.S., and 310 whites from Allegheny 
County, Pennsylvania, U.S. Recently 300 Koreans in South Korea were added to the study 
population. All participants were free of clinical cardiovascular disease, type I diabetes, or other 
severe disease.5  
The ERA-JUMP study reported main findings: 1) Lower levels of carotid IMT and lower 
prevalence of coronary calcification in Japanese men than U.S. white men.5 2) Lower prevalence 
of coronary calcification in Japanese men than Japanese American men.15 The study findings 
indicate that there are protective factors against SCD in the Japanese in Japan. The protective 
factors may not include a genetic factor, but environmental factors. In this regard, most recently, 
the ERA-JUMP study reported that high levels of marine-derived n-3 fatty acids in serum in 
Japanese men in Japan explained the lower levels of carotid IMT and lower prevalence of 
coronary calcification in Japanese in Japan than in white men.6 
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1.2.3 Different trends in CHD mortality between South Korea and Japan 
CHD mortality rates rose with a concomitant rise in serum total cholesterol in most Asian 
countries including China, India, Indonesia, South Korea, Malaysia, Philippines, Singapore, and 
Thailand.16 CHD mortality rates in South Korea and Japan were relatively low among the Asian 
Pacific regions.17 Age-adjusted mortality rates from CHD in South Korea increased between 
1984 and 1999.18 However, the mortality rates in Japan have decreased since the 1970s. In 
particular, CHD mortality in men aged 35-44 years of the post WWII birth cohort in South Korea 
increased steadily from 1985 to 1992 while it did not in Japan.4 When comparing the mortality 
rates between the two countries, CHD mortality in South Korea has exceeded that in Japan since 
the late 1980s.4 (Figure 2) 
 
 
Figure 2 Coronary heart disease mortality rates in South Korea and Japan 
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The post WWII birth cohort may reflect recent changes in risk factors for CHD, caused 
by the impact of westernization of lifestyle. Hence, the risk for CHD in this birth cohort 
measured by the markers of SCD may better reflect the current trends in CHD mortality rather 
ion in SCD rates using carotid 
IMT levels may be an epidemiological tool to help delineate a recent or future variation in CHD 
rates across countries, especially between South Korea and Japan. 
 
than age-adjusted mortality or the mortality in an old age group. 
1.2.4 Carotid intima-media thickness as a predictor of cardiovascular disease 
A level of carotid IMT is a surrogate and intermediate end point of early atherosclerosis. 
Increased carotid IMT is associated with cardiovascular risk factors in various population groups, 
even in young or middle-aged and various ethnic groups (e.g., Koreans and the Japanese) (Table 
1).19-24 Moreover, an increased level of carotid IMT is a predictor of incidences of myocardial 
infarction and stroke in middle-aged or elderly groups and various ethnic groups (e.g., American, 
Japanese, Dutch and German population groups).25-31 (Table 2; Table 3) A meta analysis 
demonstrated that the risk for myocardial infarction significantly increased by 15% per an 0.10 
nm increase (or 26% per a standard deviation increase) of IMT score and the risk for stroke 
significantly increased by 18% per an 0.10 nm increase (or 32% per a standard deviation 
increase) of IMT score.25 In this regard, the identification of variat
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 Table 1 A ca ar risk r oun
Year  
sign tion 
ssociations of rdiovascul  factors with ca otid IMT in y g or middle-aged adults 
Publ Authors and 
origin
Outcome Study de Popula Results 
(Multivariate OR /β ) 
1999 Ferrieres J et 
 
al.19  
from France 
Mean IMT: 
CCA 
Cross – 
sectional Caucasians 
Aged 35-65 y 
) 
 (p=.02) 
  
1,013 In 536 men, β  
Smoking: 1.48 (p=.007
SBP: 1.44 (p<.0001), 
HDL-C:-28.3
Alcohol: -2.65 (p=.001)
2001 t 
Muscatine 
Study 
from 
CCA, bif, & 
ICA 
Prospective 725 
Aged 33-42 y 
: 
L-
 
Davis PH e
al.20 
Maximal 
IMT: 
In men,  OR 
Childhood cholesterol: 
1.53 (1.19-1.96) 
Young adulthood LDL-C
1.39 (1.09-1.76) 
Young adulthood HD
C: .70 (0.52-0.93)
Current LDL-C:       
2.00 (1.50-2.67)  
2003 
Bogalusa 
Heart Study 
from CCA, 
bif, & ICA 
Prospective 486  
Aged 25-37 y  
        
  
  
DL-C: 
Li S et al.21 Mean IMT: OR  Childhood BMI:   
1.25 (1.01-1.54) 
Childhood LDL-C:   
1.42 (1.14-1.78) 
Adulthood SBP:       
1.36 (1.08-1.72) 
Adulthood HDL-C:  
0.67 (0.51-0.88) 
Adulthood L
1.46(1.16-1.82) 
2003 Raitakari 
.22 
 
Young Finns
OT et al
The CV 
Risk in
 
Left CCA 
IMT 
Prospective 2,229 Whites 
Aged 24-39 y 
 
004) 
, β  
: 0.010 Study 
Current, β   
BMI: 0.011 (p<.001)   
SBP: 0.010 (p<.001)
Smoking: 0.011 (p=.
Childhood
Plus LDL-C
(p=.001) 
2004 Tatsukawa 
 
from Japan
M et al.23   
 
Mean IMT: 
CCA 
Cross – 
sectional 
,442 
 
I city:  1,078 
K town: 2,364 
.94-0.99) 
94) 
), 
(1.01-1.02) 
3
Aged 20-89 y
 
I city, OR 
LDL-C: 1.02 (1.01-1.02) 
HDL: 0.96 (0
Diabetes: 2.59 (1.35-4.
K town, OR 
SBP:1.03 (1.01-1.04
LDL-C:1.01
2006 Lee YH et 
al.24 
form Korea  
CCA, bif, & 
ICA 
sectional Aged 20-75y (n=248), β  
HTN: .22 (p<.001)
Mean IMT: Cross – 1,507 
 
In men aged <50 y 
Publ=publication; IMT=intima-media thickness; CCA=common carotid artery; bif=bifurcation; 
ICA=internal carotid artery; SBP= systolic blood pressure; HDL-C=high density lipoprotein 
cholesterol; LDL-C=low-density lipoprotein cholesterol; BMI=body mass index; HTN=hypertension 
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 Table 2 T as a  in HD a the U dies 
Year 
Points n 
Carotid IM  predictor of cident C nd Stroke in nited Stu
Publ Authors End Design Populatio Results 
1997 Chambless 
udy 
MI Prospective 
(4-7 y) 
12,841  
Aged  45-64 y 
  bif;CCA;ICA 
LE et al.26 
 
ARIC St
HRR: >=1mm vs. <1mm 
5.07 (3.08-8.36) for women 
1.85 (1.28-2.69) from men 
*mean IMT from
1999 O’Leary DH 
  
 
MI, stroke Prospective 
(6.2 y) 
5,858 
Aged>=65 y 
 per 1 SD increase 
et al.27
CHS 
RR for MI per 1 SD increase 
1.36 (1.23-1.52) 
RR for Stroke
1.33 (1.20-1.47)   
 *CCA;ICA  
2000 Chambless Ischemic 
Stroke 
Prospective 
(6-7 y) 
15,792  
Aged  45-64 y 
 mm 
 
LE et al.28 
 
ARIC Study 
3.6 (1.5-9.2) for men 
*mean IMT from  bif;CCA;ICA
HRR: >=1mm vs. <0.6
8.5 (3.5-20.7) for women 
Publ=publication; IMT=intima-media thickness; MI=myocardial infarction; ARIC=Atherosclerosis 
Risk In Communities; HRR=hazard relative risk; CHS=Cardiovascular Heart Study; bif=bifurcation; 
CCA=common carotid artery; ICA=internal carotid artery; RR=relative risk; SD=standard deviation 
 
Table 3 Car s a p VD rope 
Year 
lation 
otid IMT a redictor of C risk in Eu and Japan 
Publ Authors End Points Design Popu Results 
1997 L et al.29 
Rotterdam 
MI , stroke case 
-control 
7,983 
Aged >=55 y 
 MI, 1.25 (0.98-1.58) 
4 (1.08-
Bots M
Study 
Nested 
(2.7 y) 
OR for
OR for stroke, 1.3
1.67) 
*IMT from CCA 
2004 Kitamura A et 
 
al.30  
from Japan 
Stroke Prospective 
(4.5 y) 
1,289 men 
Aged 60-74y CA and 
 CCA;ICA IMT  
RR: 5.2  
>=1.07 mm  of C
>=1.93 of ICA vs. <1.07 
mm and < 1.93  
* IMT from
2005 urakami S et 
Japan
M
al.31 
 
LILAC Study 
from  
ular 
Prospective 
(3.2 y) 
298 
Aged > 75y 
lity, left vs. All-
cause/vasc
mortality 
All-cause morta
right IMT 
RR 1.6 vs. 3.3 
Cardiovascular mortality 
RR 2.4 vs. 2.9 
2006 orenz MW et L
al.32 
 
CAPS 
(from German)  
* IMT from 
Bif;CCA;bulb 
MI, stroke, or death: 1.17 
(1.08-1.26)  
MI, stroke 
or 
death 
Prospective 
(4.2 y) 
,056 SD 
0.97-1.28) 
5
Aged 19-90y 
 
HRR for CCA IMT per 1
MI: 1.16 (1.05-1.27)  
Stroke: 1.11 (
KIHD=Kuopio Ischemic Heart Disease; LILAC Study=Longitudinal Investigation for the Longevity 
and Aging in Hokkaido County; CAPS=Carotid Atherosclerosis Progression Study; OR=odds ratio 
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1.2.5 Polyunsaturated fatty acids (n-3 and n-6) and cardiovascular disease 
Polyunsaturated fatty acids (PUFA) are essential fatty acids, which are obtained only from intake 
of foods. They are divided into two major compositions (Table 4). One is n-3 PUFA and the 
other is n-6 PUFA. The primary sources of n-3 are alpha-linolenic acids (ALA, 18:3n-3), 
eicosapentanoic acids (EPA, 20:5n-3) and docosahexanoic acids (DHA, 22:6n-3). ALA is called 
plant-derived n-3 PUFA which is found mostly in flaxeed oil or soybeans. EPA and DHA are 
called marine-derived n-3 PUFAs which are primarily found in fish. The primary source of n-6 is 
linoleic acid (LA, 18:2n-6) which is present mostly in corn, sunflower and safflower oils. 
Additionally, other fatty acids include monounsaturated fatty acids (MUFA), saturated fatty 
acids (SFA) and trans-fatty acids (TFA) (Table 4).  
 
Table 4 Fatty acid compositions and their food sources 
Fatty acids Composition Sources 
Polyunsaturated fatty acids 
(PUFA)  
N-3  Alpha-linolenic acid (ALA, 18:3n3)  Flaxeed oil 
  Eicosapentaenoic acid (EPA, 20:5n3) 
Docosahexataenoic acid (DHA, 
22:6n3)  
Fish (e.g., salmon, 
herring, and 
anchovy) 
 N-6  Linoleic acid (LA, 18:3n6)  Corn oil 
Sunflower oil 
Safflower oil  
  Arachidonic acid (AA, 20:4n6)  Meat, eggs  
Monounsaturated fatty acids 
(MUFA)  
Oleic acid (18:1n9) Olive oil  
Saturated fatty acids (SFA)  Palmitic acid (16:0) 
Stearic acid (18:0) 
Animal fat  
Trans fatty acids (TFA)  16:1t  
18:1t 
18:2tt 
Hydrogenated oil  
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Epidemiological or clinical studies demonstrated that n-3 PUFA protects against CHD.33-
37 Marine-derived n-3 intakes have a wide range of favorable effects on coronary risk factors, 
including hypotriglyceridemic, antithrombotic, anti-inflammatory and hypotensive effects. 38 
There is evidence that the marine derived n-3 PUFA, especially EPA and DHA, is significantly 
related to the reduction of CVD risk, which is known to be mostly due to anti-arrhythmic effect. 
The anti-arrhythmic effects were consistently reported at least one or two servings per week of 
fish consumption in western countries.39 However, it has been controversial on its 
antiatherogenic effect such as the reduction of non-fatal CHD (Table 5). Statistically non-
significant results in the antiatherogenic effects may be possibly due to a low treatment dose of 
fish intake or fish oil in studies conducted in Western countries.40, 41 However, statistically 
significant results have been reported in prospective or clinical trials conducted in Japanese in 
Japan where the population level of fish intake is relatively high.35, 36 The Japanese are well 
acknowledged to be one of the populations who consume the highest intake of fish in the world. 
According to the International Study on Macronutrients and Blood pressure (INTERMAP) 
Study, Japan consumed the greatest intake of fish, estimated by marine-derived n-3 PUFA, 
among the studied countries (i.e., Japan, China, United Kingdom, and United States) and almost 
twice that of the U.S.42 (Figure 3). 
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Figure 3 Marine-derived n-3 polyunsaturated fatty acids across Japan, China, United Kingdom, and 
United States (Zhou BF et al. [2003] from INTERMAP Study) 
PUFA=polyunsaturated fatty acids 
 
A diet-heart hypothesis may provide the foundation for an explanation of the lower level 
of SCD in Japan. Recently the ERA-JUMP study demonstrated that the serum level of marine-
derived n-3 PUFAs attenuated the significant differences in multivariable-adjusted carotid IMT 
and prevalence of coronary calcification between the Japanese in Japan and U.S. whites43. The 
result indicates that the higher level of marine-derived n-3 PUFAs is a factor that may explain 
the low rates of SCD in the Japanese in Japan compared to U.S. Whites.  
The beneficial effects of n-6 PUFA was started back to the 1960s. Linoleic acid (LA), a 
primary index of n-6 PUFA, has been well-recognized to decrease low-density lipoprotein 
cholesterol (LDL-C), when it replaces either saturated or monounsaturated fatty acids.44 An 
intake of 5% - 8% energy from LA (11-20 g/day for a 2000 kcal diet) may be effective on lipid 
modification for healthy individuals.38 The Nurses’ Health Study, a prospective study for 14 year 
follow-up conducting in about 80,000 women reported that a 5 % increase of PUFA in diet 
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decreased the CHD risk by 38%.45 The National Heart, Lung, and Blood Institute Family Heart 
Study reported that the enriched diet (4.5% - 6% energy) of LA was associated with lower 
coronary artery disease.46 The cardioprotective effects of enriched LA diet have anti-thrombosis, 
anit-arrhythmia, and increasing insulin sensitivity.47 Taking into consideration a robust role of 
circulating level of fatty acids, rather than intake, the protective effects of circulating levels of 
LA against cardiovascular events have been controversial in case-control studies (Table 6).33, 48, 
49 However, according to a prospective study (i.e., the Kuopio Ischemic Heart Disease Risk 
Factor study), an increased serum level of linoleic acid was significantly associated with the 
reduction in cardiovascular mortality in 1,551 men aged 42-62 years after 15 year-follow-up.50  
Therefore, an enriched diet of LA may be effective on the reduction of cardiovascular mortality. 
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Table 5 Marine n-3 PUFA and non-fatal CHD 
Year Authors Effect End 
Points 
Design Population Results 
1995  Simon JA et 
al.33 
 
MRFIT Study 
+ CHD Nested case-
control 
94/94 men 
Aged 35-57 y 
OR of serum DPA: 0.67 
(0.47-0.95) 
OR of serum DHA:0.66 
(0.46-0.94) 
1995 Guallar E et 
al.40 
Physicians’ 
Health Study 
- MI Nested case-
control 
(5 y) 
254/222 men 
Aged 40-84 y 
RR of plasma EPA: NS 
RR of plasma DHA : 
NS 
2002 Bucher HC et 
al.41 
- Nonfatal, 
fatal MI 
Meta-
analysis of 
RCTs 
11 secondary 
prevention 
trials 
RR of fish intake for 
nonfatal: NS 
RR for fish oil for 
nonfatal: NS 
2002 Yli-Jama P et 
al.34 
Study from 
Norway  
+ MI Case-control 111/107 
Aged 45-75 y 
OR of serum marine n-
3: 0.20 (0.06-0.63) 
2002 Hu F et al.51 
 
Nurses’ 
Health Study 
+ CHD or 
CHD 
death 
Prospective 
(16 y) 
84,688 women 
Aged 34 to 59 
years 
RR of fish intake 
0.79 for 1-3 times 
/month 
0.64 for once per week 
0.69 for 2-4 times per 
week 
0.66 for 5 or more per 
week 
2006 Iso H et al.35 
 
JPHC Study 
from Japan 
+ CHD, 
MI, SCD 
Prospective 
(5 y) 
41,578  
Aged 40-59 y 
N-3 PUFA of the 
highest quintile: HRs 
CHD: 0.58 (0.35-0.97) 
 MI: 0.35 (0.18-0.66) 
Non-fatal: 0.33 (0.17-
0.63) 
SCD: NS; Fatal: NS 
2007 Yokoyama M 
et al.36 
JELIS from 
Japan 
+ CHD, 
SCD 
Prospective 
RCT (5 y) 
EPA (1800 
mg/day)  
18, 645 hyper- 
cholesterolemi
c patients 
HR for CHD: 0.81 
(0.69-0.95) 
HR for SCD: 1.06 
(0.55-2.07), NS 
2007 Harris WS et 
al.37 
+ Nonfatal 
CHD,  
fatal 
CHD 
Meta-
analysis 
25 Nested 
Case-control 
or Case-
control 
Effect size for nonfatal 
EPA+DHA: NS 
DHA: -.26 (-.01-.50) 
EPA : -.09 (.03-.21) 
+significant result; -non-significant result; PUFA=polyunsaturated fatty acids; CHD=coronary heart 
disease; CVD=cardiovascular disease; LA= linoleic acid; MI=myocardial infarction; 
MRFIT=Multiethnic Risk factor Intervention Trial; DPA= docosapentaenoic acid; OR=multivariate 
OR; RR=relative risk; JPHD=Japan Public Health Center-Based Study Cohort; SCD=sudden cardiac 
death; NS=non-significant; JELIS=Japan Eicosapentaenoic acid (EPA) Lipid Intervention Study 
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Table 6 Circulating linoleic acid and CHD 
Publ 
Year  
Authors  Effect  End 
Points  
Design  Population  Results  
1982  Miettinen 
TA, et al.48  
+ MI  Nested case-
control  
3,400 men 
40-55 y  
Serum LA (cholesterol 
ester, phospholipid, and 
triglyceride): lower in 
cases than in controls 
(23.40 % vs. 26.20%) 
1987  Wood DA et 
al.49  
+ Angina 
Pectoris  
Case-control   OR =1.2 (1.1-1.3) per 
1% decrease in LA in 
adipose tissue 
1995  Simon JA et 
al.33 
 
MRFIT 
Study  
- CHD  Nested case-
control  
94/94 men 
Aged 35-57 y 
OR of serum LA(%): 
0.83 (0.61-1.14), NS 
1996  Ohrvall M et 
al.52 
Study from 
Sweden  
-  MI  Nested case-
control 
(19 y) 
2,322 men 
Aged 50 y  
Serum LA (cholesterol 
ester): lower in cases 
(54.1 vs. 52.9%) but NS 
in multivariate models  
2002  Yli-Jama P 
et al.34 
 
Study from 
Norway  
-  MI  Case-control  111/107 
Aged 45-75 y 
OR of serum LA (%): 
1.45 (0.51-4.10), NS  
2005  Laaksonen 
DE et al.50 
KIHD Study  
+  CVD 
mortality  
Prospective 
(15 y)  
1,551 men 
Aged 42-60 y 
OR of serum LA (%): 
0.42 (0.21-0.80) 
OR of serum PUFA 
(%): 0.25 (0.12-0.50) 
CHD=coronary heart disease; CVD=cardiovascular disease; LA=linoleic acids; KIHD=Kuopio 
Ischaemic Heart Disease Risk Factor; MI=myocardial infarction; MRFIT=Multiethnic Risk factor 
Intervention Trial 
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1.2.6 Potential mediators in the associations between polyunsaturated fatty acids (n-3 and 
n-6) and CHD: Lipoprotein classes 
Lipoprotein subclasses are a feature of risk for CHD. In epidemiological studies and clinical 
trials, a specific lipoprotein particle concentration or size was related to CHD risk or subclinical 
atherosclerosis (Table 7; Table 8).  
Elevated concentrations of large very-low-density lipoprotein (VLDL) particles and total 
LDL particles have been acknowledged to be atherogenic.53 Particularly, small LDL particles 
have been paid attention to be more atherogenic than LDL-C, because its deleterious properties 
such as reduced affinity for the LDL receptor,54 longer residence time in plasma,55 and increased 
susceptibility to oxidation,56 and deleterious effects on the function of vascular cells.57 An 
elevated small LDL is closely associated with high triglycerides and low high-density lipoprotein 
cholesterol (HDL-C) and identifies metabolic syndrome with high sensitivity.58-61 Secondary 
clinical trials and case-control studies demonstrated that small LDL is associated with the risk for 
CHD.61-64 On the other hand, large HDL particles were reported to be a protective factor against 
CHD events and subclinical atherosclerosis. 65, 66 Potential capabilities for athergenesis of 
lipoprotein particle concentration and size are summarized in Table 9. In this regard, the 
lipoprotein subclasses need to be investigated as a mediator in the associations between PUFA 
and CHD. 
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Table 7 Lipoprotein particles as a predictor of CHD risk (incidence, mortality and progression) 
Publ. 
Year 
Authors  End Points  Design  Population  Results  
1997  Lamarche B et 
al.62 
 
Quebec 
Cardiovascular 
Study  
IHD  Nested case-
control  
(5 y)  
114 /103 
Aged  35-64 y  
RR for small LDL size 
(<=25.6) vs. (26.1): 3.6 
NS, after adjusting for 
LDL-C, TG, HDL-C and 
apo-B 
*Using gradient gel 
electrophoresis  
2002  Kuller L et al.67 
 
CHS  
MI, angina  Nested case-
cohort 
(2.7 y)  
434/249 
Aged >=65 y  
Total LDL-p, higher for 
the case in multivariate 
models in women (but 
not in men)  
2002  Blake GJ et al.68 
 
WHS  
MI, stroke, 
death  
Nested case-
control (3 y) 
130/130 
Aged>=65 y  
RR for  highest quartile 
of total LDL-p: 4.17 
(1.96-7.87) 
2002  Rosenson RS et 
al.63 
 
PLAC-I Trial  
Progression 
of CAD  
RCT 
(3 y)  
130/111 
Mean age 57.5 y 
OR for small  LDL-p of  
>= 30 mg/dl: 9.1 (2.1-39) 
in the placebo  
2003  Soedamah-
Muthu S et al.65 
 
EDIC Study  
CHD  Nested case-
control  
59/59 
Patients with 
type I diabetes 
 
Mean age 35 y  
OR:Medium HDL-p 3.79 
(1.17-12.25) 
      Large HDL-p 0.43 
(0.20-0.92) 
      Total VLDL 2.33 
(1.07-5.08) 
2006  Otvos JD et al.64 
 
VA-HIT  
CHD  RCT 
(5.1 y)  
364/697 men  OR for large LDL-p per 1 
SD increase: 1.34  
(1.11-1.62) 
OR for small LDL-p per 
1 SD increase: 1.41 
(1.14-1.73) 
OR for small HDL-p per 
1 SD increase: 0.67 
(0.57-0.79) 
CHS=Cardiovascular Heart Study; WHS=Women Heart Study; PLAC-I=Pravastatin Limitation of 
Atherosclerosis in the Coronary Arteries; EDC=Epidemiology of Diabetes Complication; VA-
HIT=Veterans Affairs High-Density Lipoprotein Intervention Trial; NS=non-significant; RR=relative 
risk; OR=odds ratio; LDL-C=low-density lipoprotein cholesterol; LDL-p=low-density lipoprotein 
particles; HDL-C=high-density lipoprotein cholesterol; HDL-p=high-density lipoprotein particles; 
RCT=randomized clinical trial; CHD=coronary heart diseae; CAD=coronary artery disease; 
MI=myocardial infarction; IHD=ischemic heart disease; SD=standard deviation 
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Table 8 Lipoprotein particles as a predictor of risk for subclinical atherosclerosis 
Publ. 
Year 
Authors and 
study name 
End Points Design Population Results 
2002 Mackey RH 
et al.53 
 
Healthy 
Women 
Study 
 
Coronary 
calcification 
Cross 
-sectional 
286 
Postmenopausal 
women 
Aged  42-50 y 
OR per 1 SD increase 
   Small LDL:  
1.36 (1.04-1.77) 
   LDL size:  
0.55 (0.31-0.99) 
   Total LDL-p:  
1.44 (1.04-1.99) 
   Large VLDL:  
1.59 (1.11-2.28) 
2006 Lyon TJ et 
al.69 
 
DCCT/EDIC 
 
 
Carotid IMT Retrospective 968 with Type I 
diabetes 
Aged 13-40 y 
Relation (β) to ICA  
  Large LDL-p:  
0.03 (0.01) for women vs. 
0.02 (0.01) for men 
  Small LDL-p:  
0.05 (0.02) for women vs. 
0.03 (0.01) for men 
Relation (β) to CCA 
  Large LDL-p:  
0.01 (0.01) for women vs. 
0.01 (0.01) for men 
2007 Mora S et 
al.66 
 
MESA 
 
Carotid IMT Cross 
-sectional 
5,538 
Aged 45-84 y 
Δ IMT in μm per 1 SD 
 Large LDL-p 42.9 (6.7) 
 Small LDL-p 39.1 (7.1) 
 Large HDL-p -25.1 (7.0) 
 Small HDL-p -13.2 (4.5) 
DCCT=Diabetes Control and Complication Trial; EDIC=Epidemiology of Diabetes Interventions and 
Complications; HDL-p=high-density lipoprotein particles; IMT=intima-media thickness; ICA=internal 
carotid artery; LDL-p=low-density lipoprotein particles; MESA=Multiethnic Study of Atherosclerosis 
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Table 9 Lipoprotein subclasses: Potential capability for atherogenesis 
VLDL  
  Total VLDL-p  Atherogenic  
  Large VLDL-p  Atherogenic  
  Small VLDL-p  Unknown 
LDL  
  Total LDL-p  Atherogenic  
  Large LDL-p  Atherogenic (controversial) 
  Small LDL-p  Atherogenic  
HDL  
  Total HDL-p  Unknown 
  Large HDL-p  Anti-atherogenic  
  Small HDL-p  Anit-atherogenic  
VLDL size  Unknown 
LDL size  Anti-atherogenic/null (controversial)  
HDL size  Unknown 
VLDL-p=very low-density lipoprotein particles; LDL-p=low-density 
lipoprotein particles; HDL-p=high-density lipoprotein particles 
 
 
Some, but not all, clinical trials reported beneficial effects of fish intake or fish oil 
supplementation on the modification of lipoproteinns including large VLDL, 70, 71 small LDL, 72, 
73 large HDL 70, 74, 75 and LDL size (Table 10; Table 11). 74, 76 However, few studies reported the 
beneficial effect of n-6 PUFA on the modification of lipoproteins (Table 12). 77-79 Furthermore, 
there is little evidence on the relationships of n-3/n-6 PUFA with lipoprotein subclasses across 
different population groups who have considerable variability in habitual diet (e.g., fish intake). 
 
 
 
 
 
 
 20
Table 10 Marine n-3 PUFA and lipoprotein subclasses in clinical trials  
Publ. 
Year 
Authors PUFA Tx Subjects & design Results 
1991 Fumeron F et 
al.70 
Fish oil 
supplement 
3 wks 36 healthy, young males 
(23.5 y) 
Cross-over 
1) Usual diet (70g butter) 
2) + fish oil (6g/d MaxEPA) 
3) + margarine instead of 
butter 
In the fish oil group 
↓ TG 
↓ VLDL 
↑large HDL 
1993 Contacos C et 
al.76 
Fish oil 
supplement 
6 wks 32 pts with mixed 
hyperlipidemia 
 
RCT 
1)Pravastatin (40mg/d, 
n=10) 
2)Fish oil (6g/d, 3g/d of n-3) 
3)Placebo 
In pravastatin group 
↓TC;↓LDL;↓Apo B 
(–) LDL Stokes' 
diameter 
In the fish oil group 
↓ TG; – LDL 
↑ LDL Stokes' 
diameter 
1995 Suzukawa M 
et al.80 
Fish oil 
supplement 
6 wks 20 hypertensive subjects 
Cross-over 
1)Fish oil (4g/d),  
2) Corn oil 
In the fish oil group 
↓ TG 
(–) LDL 
↑ LDL size 
2000 Mori TA et 
al.74 
Fish oil 
supplement 
6 wks 59 men aged 20-65, 
overweight, mildly 
hyperlipidemic 
 
RCT 
4g EPA oil,  
4g DHA oil, 
4g Olive oil 
*Differential effect 
↓  TG in both EPA 
and DHA 
↑  LDL; LDL size in 
DHA 
(–) HDL;↑ large 
HDL in DHA 
↓ small HDL in EPA 
2000 Minihane AM 
et al.72 
Fish oil 
supplement 
6 wks 55 atherogenic lipoprotein 
phenotype males aged 34-69 y 
Cross-over 
1) Fish oil (3g, EPA+DHA) 
2) Olive oil 
↓ TG in fasting and 
postprandial 
↓ % small LDL 
(–) HDL-C 
2002 Leigh-Firbank 
EC et al.73 
Fish oil 
supplement 
6 wks 55 mildly hyperTG men 
Cross-over 
1) Fish oil (6g/d, 3g/d of 
EPA+DHA) 
2) Olive oil (6g/d) 
↓ TG in fasting and 
postprandial 
↓ % small LDL 
↑ LDL-C 
*Differential effect 
DHA?↑LDL-C, 
EPA?↓ TG 
(–) denotes no changes; TG=triglycerides; LDL-p=low lipoprotein particles; NCE= national cholesterol 
education program; Tx=treatment; RCT=randomized clinical trial; PUFA=polyunsaturated fatty acids; 
DHA=docoxahexanoic acids; EPA=eicosapetaenoic acids 
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Table 11 Marine n-3 PUFA and lipoprotein subclasses in clinical trials/population-based studies  
Publ. 
Year  
Authors  PUFA  Tx  Subjects & design  Results  
2002  Petersen M 
et al.75  
Fish oil 
supplement  
8 wks  42 moderately 
hyperTG/type diebeteic  
 
RCT 
Fish oil (2.6g of 
EPA+DHA) 
Corn oil 
↓TG 
↑large HDL 
(–) LDL-p  
2004  Li Z et al.78 Dietary fish  24 wks 22 men and women aged 
>40 y  
 
RCT: 6 wk average 
American diet?  
NCEP step 2 diet with 
high-fishdiet (4.5% 
saturated fat, 15mg chol) 
NCEP step 2 diet with low-
fish diet (4.0% saturated 
fat, and 11mg chol) 
↓ medium and small 
VLDL in high-fish diet 
↓ LDL in both diets 
↓ HDL in both diets 
(–) LDL-p and size in 
both diet  
2007  Mostad IL  
et al.71   
Fish oil 
supplement  
9 wks 27 type 2 diabetic patients 
aged 40-75 y with 
normoTG  
 
RCT 
Fish oil (5.9 g /d , 1.8g 
EPA;3.0g DHA)  
Corn oil 
(–) T chol; –LDL-C; –
HDL-C 
↓large VLDL-
p ;↓VLDL size 
(–) All LDL-p 
↓Small HDL  
2007  Bos G et 
al.81   
Dietary total 
PUFA  
 Cross-sectional 
758 men and women with 
normal, impaired glucose 
metabolism and type II 
diabetes 
As a function of PUFA by 
stratification of glucose 
metabolic status (normal, 
impaired, diabetes)  
No association between 
LDL size and total 
PUFA in subjects with 
normal glucose 
metabolism. 
(–) denotes no changes; TG, triglycerides; LDL-p, low lipoprotein particles; NCEP, national 
cholesterol education program; Tx, treatment; RCT, randomized clinical trial; PUFA, polyunsaturated 
fatty acids; DHA, docoxahexanoic acids; EPA, eicosapetaenoic acids 
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Table 12 Linoleic acid and lipoprotein subclasses in clinical trials 
Publ 
Year  
Authors  PUFA Tx Subjects & design Results 
2005 Thijssen 
MA et al.77 
Dietary 
LA 
5 wks 45 healthy subjects (27 
women and 18men) 
Cross-over 
38% of energy from fat; 
7% of energy of each fatty 
acid 
Stearic, 
Oleic,  
LA 
Compared to other diet, 
↑ large VLDL (NS) 
↑ large HDL (NS) 
Compared to stearic diet, 
↓ small LDL  
2005 Wilkinson 
P et al.82 
Dietary 
ALA, LA, 
and marine 
n-3 
12 wks 57 healthy men aged 35-
60 y,  
With a moderately raised 
TG and low HDL-C, with 
the predominance of small 
LDL (>30%) 
RCT, three diets 
FXO (rich in flaxeed oil) 
SO (rich in sunflower oil) 
SOF (SO plus fish-oil 
capsules; 3g/d of 
EPA+DHA) 
0, 6, & 12 week follow-up 
↓Small LDL in SOF  
 (at both 6 and 12 weeks) 
↓Small LDL in FXO & 
SO  
  (NS) 
↑Large HDL in SOF  
  (at 12 weeks) 
↑Large HDL in FXO & 
SO  
  (at 12 weeks, NS) 
LA= linoleic acid; PUFA=polyunsaturated fatty acids; Tx=treatment; NS=not significant; 
RCT=randomized clinical trial; FXO=flaxeed oil ; SO=sunflower oil; SOF=sunflower oil plus fish oil; 
EPA=eicopentaenoic acids; DH=docosahexanoic aicds  
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1.2.7 Arterial stiffness measured by pulse wave velocity: a measure of subclinical 
cardiovascular disease        
Arterial stiffness can be noninvasively evaluated by measuring pulse wave velocity (PWV). 
Stiffer arteries have higher pulse wave velocity. PWV is defined as the speed of travel of the 
pressure pulse along an arterial segment. Theoretically, it can be obtained by using any two 
arterial locations accessible to palpation including heart-carotid, heart-femoral, heart-brachial, 
carotid-femoral, brachial-ankle, and femoral-ankle locations.   
PWV may be a measure of subclinical cardiovascular disease. A large amount of 
evidence showed that aortic stiffness measured by carotid-femoral PWV is a predictor of all-
cause and cardiovascular mortality, fatal and nonfatal coronary events, and fatal strokes in 
various diseases and healthy population groups, including patients with hypertension, type 2 
diabetes, and end-stage renal disease and elderly/general population.83-89 (Table 13). Moreover, 
aortic stiffness is related to early artherosclerosis.90-92 There are several potential mechanisms by 
which increased PWV is associated with cardiovascular mortality. Arterial stiffness is associated 
with left ventricular hypertrophy in normotensive and hypertensive patients,93, 94 which increases 
the risk for congestive heart failure and cardiovascular events.95 Arterial stiffness increases 
systolic blood pressure and decreases diastolic blood pressure, which raises left ventricular 
afterload and myocardial work and reduces coronary perfusion, respectively.96 Arterial stiffness 
is also associated with atherosclerosis,97 probably through the effects of cyclic stress on arterial 
wall thickening.98, 99  
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1.2.8 Indices of arterial stiffness: carotid-femoral PWV versus brachial-ankle PWV        
     Carotid-femoral PWV measured by Doppler ultrasound is an established index of aortic 
stiffness. For this reason, the carotid-femoral PWV is a gold standard measure because the aorta 
is recognized as the important vessel to evaluate arterial stiffness. Alternatively, brachial-ankle 
PWV has been recently received attention, because it has potential as a new marker of 
cardiovascular risk and because it is a simple and practical methodology for clinical practice and 
large-scale population studies.100, 101 Criticisms on the brachial-ankle PWV have been 
recognized, because brachial and post-tibial arteries are considered to be peripheral muscular 
arteries. Compared to central elastic arteries, peripheral arteries do not appear to change 
significantly with aging and disease state. However, recent evidence showed that brachial-ankle 
PWV was a better correlate of early atherosclerosis in postmenopausal women.91 In small 
cohorts of either elderly community-dwelling people or coronary heart disease patients, brachial-
ankle PWV was an independent predictor for cardiovascular deaths and events.101 
An increase in PWV may be a result of structural and functional changes of the vascular 
tree, 102 which are mainly related to aging process and high mean arterial pressure103, 104 and 
additionally related to other cardiovascular risk factors. 92, 104  The changes of stiffness in the 
vascular tree may differ by properties of arterial wall (i.e., the central artery vs. the peripheral 
artery). Studies reported that age-related increases in PWV differed by the arterial properties. 
The central arteries become stiffer with aging,105-107while the peripheral arteries may not be 
similarly influenced by aging.103 The central artery wall has numerous elastic membranes and 
fibers, while the peripheral artery wall has slight elastic tissue and numerous smooth muscle 
cells.108 In this regard, the characteristics of PWV associated with cardiovascular risk factors 
may differ by arterial segments, especially carotid-femoral PWV vs. brachial-ankle PWV. 
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Table 13 Prospective studies reporting predictive value of aortic pulse wave velocity 
Year Authors Study design Study 
population 
End points Results (multivariate) 
2001 Laurent (France)83  Prospective 
cohort (≈9 y)   
1980 essential 
hypertensive 
patients (mean 
age, 50 y) 
CVD 
mortality 
OR of 5 m/s increase in 
PWV  
Cardiovascular mortality: 
1.51 (1.08 – 2.11) 
2002 Boutouyrie 
(France)84 
Prospective 
cohort 
(5.7 y) 
1045 
hypertensive 
patients (mean 
age, 51 y) 
CHD 
mortality 
CVD 
mortality 
RR of 10.0-12.3 m/s vs. <10.0 
m/s 
CHD 1.63 (1.13 – 2.36) 
CVD  1.22 (0.91 – 1.65)\ 
RR of >12.3 m/s vs. <10.0 m/s 
CHD 2.66 (1.27 – 5.56) 
CVD 1.49 (0.82 – 2.71) 
2003 Laurent (France)85 Prospective 
cohort 
(7.9 y) 
1715 essential 
hypertensive 
patients 
(mean age, 51 y) 
Stroke 
death 
RR of 4 m/s increase in PWV 
Stroke death 1.39 (1.08 – 
1.72) 
2005 Sutton-Tyrrell K et 
al.86 
The Health, Aging 
and Body 
Composition 
(ABC) Study 
 
Prospective 
cohort 
(4.6 y) 
 
2488 men and 
women 
Aged 70-79 y 
(mean age, 74 y) 
 
Total 
mortality 
CVD 
mortality 
CHD 
Stroke 
RR compared to the lowest 
quartile of PWV  
Total mortality, 1.60 (1.10-
2.32)  
CVD mortality, 1.98 (1.03-
3.81)  
CHD, 1.53 (1.09-2.13)  
Stroke, 3.21 (1.56-6.63) 
2005 Shokawa T et al.87 
Hawaii-Los Angeles -
Hiroshima long-term 
epidemiological study 
Prospective 
cohort 
(10 y) 
492 men and 
women 
Japanese-
Americans 
living in Hawaii 
(mean age, 64 y) 
All-cause 
mortality 
CVD 
mortality 
Using the cut-off value of PWV 
(9.9 m/s) 
RR 
All cause mortality, 1.42 
(0.96-2.11) 
CVD mortality, 4.24 (1.36-
12.96) 
2006 Mattace-Raso FUS 
et al. 
The Rotterdam 
Study88 
 
 
Prospective 
cohort 
(4.1 y) 
2835 healthy 
men and women 
Aged >=55 y 
(mean age, 72 y; 
39% of men) 
CVD/CHD 
Stroke 
All-cause 
mortality 
HR compared to the lowest 
tertile of PWV index 
CVD, 1.93 (1.16-3.21)  
CHD, 20.7 (1.08-3.98)  
Stroke, 1.94 (0.94-4.29) 
All-cause mortality, 1.39 
(0.99-1.96) 
2006 Willum-Hansen T 
et al.89 
 
 
 
Prospective 
(9.4 y) 
1678 Danes 
Aged 40-70 y 
CVD 
CVD 
mortality 
CHD 
 
HR  
 CVD, 1.14 (1.00-1.29)  
 CVD mortality, 1.14 (0.95-
1.36) 
 CHD, 1.12 (0.95-1.31) 
CVD=cardiovascular disease; CHD=coronary heart disease; PWV=pulse wave velocity; HR=hazard ratio; 
CI=confidence interval; RR=relative risk; OR=odds ratio  
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2.1 ABSTRACT 
Purpose: Koreans are recently at higher risk for coronary heart disease than are the Japanese. 
We aimed to evaluate levels of carotid intima-media thickness (IMT) and coronary risk factors in 
Korean and Japanese men in the post World War II birth cohort. METHODS: We conducted a 
population-based study of 352 randomly-selected healthy men aged 40-49 years: 102 Koreans in 
Ansan City, Gyeonggi-do, Korea and 250 Japanese in Kusatsu City, Shiga, Japan. Imaging 
carotid IMT by ultrasound and other procedures were standardized. Analyzing blood samples 
and reading carotid IMT were performed at the University of Pittsburgh. RESULTS: Despite 
more favorable or similar features in coronary risk factors as compared to the Japanese men, the 
Korean men had a higher crude IMT level than the Japanese men (mean ± s.e., .655 ± .008 mm 
versus .616 ± .005 mm, respectively, p<.0001). The difference in the levels of carotid IMT 
significantly remained after adjusting for metabolic and conventional risk factors (.654± .008 
mm versus .616 ± .005 mm, respectively, p<.0001). CONCLUSIONS: Among men aged 40-49, 
Koreans had significantly higher levels of carotid IMT than the Japanese. Factors that underlie 
the different susceptibility to subclinical atherosclerosis need to be explored.   
 
Keywords: atherosclerosis, carotid artery, cohort studies, coronary disease, Japanese, Koreans  
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2.2 INTRODUCTION 
Among the Asian-Pacific region, Korea and Japan had relatively low coronary heart disease 
(CHD) mortality rates.1 However, CHD mortality rate in Korea has been increasing since the 
1980s as in many other Asian countries, whereas that in Japan has been decreasing since the 
1970s.1, 2 Among men in the post World War II (WWII) cohort, the CHD mortality rate in Korea 
has, in fact, exceeded that in Japan since the late 1980s.3  
Compared to other Asian countries, Korea and Japan, closely located in East Asia, have 
relative similarity in socio-cultural and genetic background.1, 4, 5 Furthermore, the post WWII 
birth cohorts of the two countries are more likely to have adopted a westernized lifestyle than the 
old cohorts. 3 Thus, a study on the comparison of CHD risk between Korean and Japanese 
populations in the post WWII birth cohorts may provide a powerful epidemiological tool for 
understanding the different trends in CHD mortality.  
Carotid intima-media thickness (IMT) is a surrogate marker of general atherosclerosis. 6 
Increased carotid IMT is positively associated with coronary risk factors 7, 8 and future 
cardiovascular events.9 We have previously reported the difference in carotid IMT among men in 
the post WWII birth cohort between Japan and the U.S.10 However, few studies have evaluated 
levels of carotid IMT in different ethnic cohorts of Asian populations. The purpose of the study 
is to determine whether there is a significant difference in levels of carotid IMT between Korean 
and Japanese men aged 40-49 years from population-based samples.  
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2.3 METHODS 
2.3.1 Study population 
Participants were population-based samples of 352 randomly-selected men aged 40-49: 102 
Koreans in Ansan City, Gyeonggi-do, Korea and 250 Japanese in Kusatsu City, Shiga, Japan. 
Exclusion criteria were 1) clinical cardiovascular disease, 2) type I diabetes, 3) cancer except 
skin cancer in the past two years, 4) renal failure, and 5) genetic familial hyperlipidemias. All 
exclusion criteria were self-reported. 
The 102 Koreans were randomly selected from the Korean Health and Genome Study 
(KHGS), an ongoing population-based prospective cohort study. 11 The target population was all 
non-institutionalized residents aged 40-69 of Ansan City, Gyeonggi-Do, Korea. By using the 
telephone directory of Ansan City, the KHGS randomly selected 5,020 participants, who had 
three consecutive cohorts (at the end of year 2002, 2004 and 2006). For this study, using the 
Ansan cohort in year 2004, we adopted a stratified random sampling by 2-year interval age 
groups (i.e. 40-41, 42-43, 44-45, 46-47, and 48-49), each including about 20 individuals. After 
extracting a list of 1,375 men aged 40-49, we contacted them at each age group by phone in 
randomly generated order. After 192 calls, 92 subjects took part in this study. The response rate 
was approximately 50%. Since the KHGS had an insufficient number of subjects aged 40-41 in 
2004, we additionally enrolled 10 volunteers in the community.   
The 250 Japanese men who resided in Kusatsu City, Shiga, Japan, were randomly 
selected from the Basic Residents' Register during 2003 – 2004.10 Each selected man was mailed 
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an invitation to the study to determine his willingness to participation. The response rate was 
approximately 50%.  
Informed consent was obtained from all participants. The study was approved by the 
Institutional Review Boards of Korea University (in Seoul, Korea), Shiga University of Medical 
Science (in Otsu, Japan), and the University of Pittsburgh (in Pittsburgh, Pennsylvania, U.S.). 
2.3.2 Carotid IMT 
A Titan (Sonosite) high-resolution ultrasound system with a 10.5 MHz linear array was used at 
the Korean site. A Toshiba 140A scanner equipped with a 7.5 MHz-linear-array imaging probe 
was used at the Japanese site. For the common carotid arteries, both near and far walls were 
examined approximately 1 cm proximal to the bulb; for the bulb and internal carotid arteries, 
only far walls were examined. The digitally stored scans were then analyzed by trained readers, 
at the Ultrasound Research Laboratory of the University of Pittsburgh, who were blind to the 
details of the study subjects. The IMT scores from each location in right and left sides were 
averaged to produce an overall score. The IMT scores were highly reproducible, demonstrating 
the estimate of correlations between scans performed by different readers (inter-reader 
reliability) was 0.99.12  
In order to reduce an observer bias and to assure the scanning quality,12 sonographers of 
both sites were given 3-day training sessions for carotid scanning by a sonographer at the 
Ultrasound Research Laboratory of the University of Pittsburgh and the quality of the scanning 
was continuously monitored. 
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2.3.3 Coronary risk factors 
Physical examinations and questionnaires were standardized between the two research sites. 
Body mass index (BMI) was calculated using body weight and height (kg/m2). Waist 
circumference was measured at the level of the umbilicus while a participant was standing erect. 
Blood pressure was measured on the right arm in the seating position after a 5-minute rest with 
the bladder emptied, by using an automated sphygmomanometer (BP-8800, Colin Medical 
Technology, Komaki, Japan). An average of two measurements was used. 
Venipuncture was performed early in a clinic visit after a 12-hour fast. All blood samples 
obtained at each research site were shipped on dry ice to the University of Pittsburgh after stored 
at -80 ◦C. Biochemical measurements of the blood samples were centralized at the Heinz 
Laboratory of the University of Pittsburgh. Serum lipids were determined with the standardized 
methods according to the Centers for Disease Control and Prevention, including total cholesterol 
(TC), low-density-lipoprotein cholesterol (LDL-C), high-density-lipoprotein cholesterol (HDL-
C), and triglycerides.13 Serum fasting glucose was determined by a hexokinaseglucose-6-
phosphate-dehydrogenase-enzymatic assay; serum fasting insulin by a radio-immuno assay 
(Linco Research Inc., St. Charles, Missouri). 
Data for smoking were collected with categories of non-, past- and current smoker. 
Current smokers were defined as cigarette smokers over the last 30 days. Pack-years of smoking 
were calculated as years of smoking multiplied by number of cigarettes smoked per day divided 
by 20. Alcohol drinkers were defined as those who drank alcohol two days per week or more. 
Ethanol consumption (g/day) was estimated, assuming that concentrations of alcohol were 5% 
for beer, 12% for wine, 40% for liquor, 16% for soju (Korean rice wine), and 16% for sake 
(Japanese rice wine). Hypertension was defined as systolic blood pressure ≥ 140 mmHg, 
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diastolic blood pressure ≥ 90 mmHg, or use of antihypertensive medications. Diabetes mellitus 
(type II) was defined as a serum fasting glucose level ≥ 126 mg/dL or use of diabetic 
medications. Education years were also collected. Prevalence of metabolic syndrome was 
assessed as having three or more components among the criteria proposed by the National 
Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III).14  
2.3.4 Statistical analyses 
To compare coronary risk factors between the two populations, a t-test or Wilcoxon rank sum 
test for continuous variables and the chi-square test or Fisher’s exact test for dichotomous 
variables were used. To examine associations of carotid IMT with coronary risk factors within 
each population, Pearson (r) or Spearman (ρ) correlation coefficients for continuous variables 
and regression coefficients (β) of the linear regression for dichotomous or ordinal variables were 
obtained. Two dummy variables for smoking (past and current) were designed and a p-value for 
smoking was obtained by p-for-trend test.  
To examine an independent association between ethnicity (Korean or Japanese) and 
carotid IMT, the linear regression model was conducted by adjustment for potential confounders 
in four steps of modeling (crude, model I, II, and III,) where adjusted-means of carotid IMT for 
the two populations were calculated. Ethnicity was entered to calculate the crude means of IMT 
in both populations. Traditional risk factors (age, BMI, DBP, LDL-C, TC/HDL-C ratio, log-
transformed TG, glucose, insulin, and pack-years of smoking) were entered in Model I, followed 
by metabolic syndrome and ethanol consumption in model II, and by other risk factors 
(education years, hypertension, diabetes, and use of lipid lowering medications) in model III.   
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All p-values were two-tailed. A P-value of <.05 was considered as significant. STATA 
9.0 (StataCorp LP, College Station, Texas, USA) was used for all statistical analyses. 
2.4 RESULTS 
The Korean men had more favorable features than the Japanese men in TC, LDL-C, fasting 
glucose, smoking, and pack years of smoking; similar features in age, SBP, triglycerides, 
TC/HDL-C ratio, ethanol consumption, hypertension, diabetes, and use of lipid-lowering 
medications (Table 14). However, the Korean men had less favorable features in BMI, DBP, 
HDL-C, and fasting insulin. 
The Korean men had significantly positive associations of carotid IMT with age, TC, 
systolic and diastolic BP, and prevalence of metabolic syndrome. The Japanese men had 
significantly positive associations of the carotid IMT with age, BMI, systolic and diastolic BP, 
LDL-C, TC /HDL-C ratio, fasting glucose, prevalence of metabolic syndrome, hypertension and 
diabetes (Table 15).  
The distribution of carotid IMT was near-normal both in the Korean and Japanese men 
(Figure 4). The crude IMT was significantly greater in the Korean men than in the Japanese men 
(Table 16); the difference in the crude IMT was .039 mm. After adjusting for age, BMI, DBP, 
TC/HDL-C ratio, LDL-C, log-transformed TG, glucose, insulin, and pack-years of smoking 
(model I), the significant difference remained in the IMT. Further adjusting for metabolic 
syndrome and ethanol consumption (model II) and further adjusting for other factors (model III) 
did not alter the result. 
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To examine if light-to-moderate ethanol consumption explained the difference in IMT 
between the populations, we categorized the continuous variable of ethanol consumption into 0, 
>0-15, >15-30, and >30 g/day. We found no significant difference in IMT across the categories 
of ethanol consumption in either population; moreover, no change in the difference in IMT 
between populations when we placed the categorical ethanol consumption in the crude model.  
2.5 DISCUSSION 
 This report is the first to examine the difference in levels of carotid IMT between Koreans and 
the Japanese in a population-based study. We found that, among men aged 40-49 years, the 
levels of carotid IMT were significantly greater in the Korean men than in the Japanese men. 
This difference was independent of metabolic and conventional risk factors.  
Since increased carotid IMT is associated with CHD incidence and recurrence,9, 15 our 
results suggest that middle-aged Korean men may continue to be at more increased risk for CHD 
than the Japanese men at least over the near future. Increased carotid IMT is also associated with 
stroke incidence and mortality.9 Our observation of significantly greater IMT levels in the 
Korean men than in the Japanese men may be in accordance with the fact from the vital statistics 
that Korean men have higher stroke mortality than the Japanese men.16  
The Korean men had lower levels of TC, LDL-C, and HDL-C than the Japanese men. 
These observations were consistent to those in previous studies.8, 17 Lower TC and LDL-C levels 
in Koreans may reflect relatively lower fat intake of total energy intake than those in the 
Japanese. Recent rapid economic growth has allowed Koreans to have an accelerating concurrent 
shift to westernized diet pattern, which has led to an increase in average total fat intake, from 
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14% of energy intake in 1986 to ≈20% in 200218. The total fat intake, however, is still lower in 
Korea than that in Japan (23.7%).19 
Although many coronary risk factors were associated with carotid IMT as expected in 
each population, some risk factors showed weaker associations with IMT in the Korean men than 
in the Japanese men, including SBP, BMI, LDL, fasting glucose, hypertension and diabetes. The 
weaker associations are likely to be due to the small sample size of the Koreans. In addition, the 
lack of the significant association of LDL-C with IMT in the Korean men may be due to a small 
variability of LDL-C level. 
The significant difference in carotid IMT scores between the two populations remained 
after adjusting for metabolic and conventional risk factors. This finding indicates that metabolic 
and conventional risk factors hardly explained the higher IMT in the Korean men than in the 
Japanese men. Genetic factors may be unlikely to explain the difference in the carotid IMT since 
it has been well known that Koreans and the Japanese are genetically similar4, 5. It was also 
reported that Japanese Americans have higher IMT levels than the native Japanese or 
Caucasians.20, 21 In this context, we may assume that higher carotid IMT in the Korean men than 
in the Japanese men may be explained by environmental factors other than factors examined in 
the present study. 
Some epidemiological studies reported a J-shaped association between ethanol 
consumption and carotid atherosclerosis,22 although conflicting results have been reported.22-25 
We did not observe a J-shaped association in either population. Furthermore, the significant 
difference in IMT remained after adjusting for ethanol consumption. Thus, we have no evidence 
that ethanol consumption is likely to explain the difference in IMT between the two populations. 
 36
Differences in fat intake quality (e.g. polyunsaturated fatty acids, omega-3 fatty acids) 
between two populations may contribute to the difference in carotid IMT. Koreans consume 
relatively less fish of 60g per day than the Japanese population who has been well known to 
uniquely have high fish consumption, 120g per day.26, 27 Hino et al. reported that omega-3 fatty 
acids intakes (e.g. eicosapentaenoic acid [EPA] or docosahexaenoic acid [DHA]) in fish had an 
inverse association with carotid IMT.28 Thus, high fish consumption, rich in EPA and DHA, may 
be protective against carotid atherosclerosis, which might in part explain the higher carotid IMT 
in Koreans than the Japanese. 
The study has several limitations. First, the fact that the study population is confined to 
men aged 40 to 49 years may limit generalization to older individuals and women. Second, we 
had a relatively small sample size of Koreans (n=102) compared to the Japanese (n=250). 
However, the levels of coronary risk factors and carotid IMT level in Koreans were not different 
from those reported in other studies.29 Third, we had limited data for socio-environmental and 
behavioral factors (i.e. income, lifestyle, physical activity) that may be potential confounders. 
The two urban cities, chosen in this study, locate within a closed geographic zone determined by 
longitude and latitude. However, they are fairly different by population and industry. Ansan (in 
Korea) located near in Seoul, is a planned urban city of over 700,000 populations with a large 
industrial complex; Kusatsu (in Japan), located near in Kyoto City, is a city of over 110,000 
populations, developed with service industry (hotels, etc.). Finally, with regard to IMT 
measurement by different machines, the difference was no greater than the variation between 
sonographers when evaluating between-machine differences. In addition, the two machines were 
comparable in the image quality. Thus, we believe that the variation in measurement due to the 
machine is relatively small.  
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Our finding suggests that higher level of carotid IMT in Koreans in the post World War II 
birth cohort may reflect a more increase risk for CHD than the Japanese. Further research is 
required to explore factors explaining the variation in carotid IMT between the two populations.
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     Table 14 Coronary risk factors between Korean and Japanese men 
 Korean (n=102) Japanese (n=250) P-value 
Age (years) 44.8±2.8 45.2±2.8 .283 
BMI (kg/m2) 24.6±2.5 23.8±3.1 .001 
Waist circumference (cm) 84.2±7.2 85.3±8.3 .421 
SBP (mmHg) 123.8±15.0 125.1±16.4 .601 
DBP (mmHg) 80.0±11.5 76.5±11.9 .006 
TC (mg/dL) 182.0±27.6 218.5±36.3 <.001 
LDL-C (mg/dL) 111.3±27.2 134.1±35.5 <.001 
HDL-C (mg/dL) 41.9±9.3 53.6±12.9 <.001 
TG (mg/dL) 122.5 (92-173) 137.5 (104-181) .124 
TC/HDL-C ratio 4.5±1.1 4.3±1.3 .117 
Fasting glucose (mg/dL) 100.0±12.2 105.9±16.0 <.001 
Fasting insulin (µIU/mL) 11.5±4.8 10.4±4.5 .026 
Education (years) 13.3±.3 14.3±.1 .001 
Metabolic syndrome, yes (%) 14.7 12.8 .633 
Smoking   .009 
  Current, yes (%) 33.3 49.2  
  Past, yes (%) 34.0 38.2  
Pack-years of smoking 10.3 (0-23) 18.9 (3-30) .003 
Alcohol drinking, yes (%) 38.0 66.8 >.999 
Ethanol consumption (g/day) 10.0 (1.8-71.4) 14.3 (2.0-42.5) .184 
Hypertension, yes (%) 21.6 26.4 .416 
Diabetes mellitus, yes (%) 3.9 4.8 >.999 
Lipid lowering medication, yes (%) 2.0 3.2 .730 
Abbreviation: BMI, body-mass index; SBP, systolic blood pressure; DBP, diastolic blood 
pressure; TC, total cholesterol; HDL-C, high-density-lipoprotein cholesterol; LDL-C, 
low-density-lipoprotein cholesterol; TG, triglycerides 
Values are expressed as mean and standard deviation (SD) or median and inter-quartile 
range for continuous variables. 
Metabolic syndrome denotes > three risk factors defined by NCEP-ATP III 
Alcohol drinking denotes > two times of alcohol drinking per week 
For continuous variables, a t-test or Wilconxon rank sum test was performed; for 
dichotomous variables, the chi-square test or Fisher’s exact test 
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 Table 15  Associations between carotid IMT and coronary risk factors within each population 
  Korean (n=102) Japanese (n=250) 
Age (years)        .34***  .25*** 
BMI (kg/m2)  .11  .32*** 
Waist circumference (cm)  .11  .26*** 
SBP (mmHg)    .24*  .19** 
DBP (mmHg)     .29**  .17** 
TC (mg/dL)   .24*  .12 
LDL-C (mg/dL)  .15  .16* 
HDL-C (mmol/L)  .03                    -.12 
TG (mmol/L)  .03  .01 
TC/HDL-C ratio  .12  .19** 
Fasting glucose (mg/dL)  .14  .19** 
Fasting insulin (µIU/mL)  -.01  .04 
Pack-years of smoking (years)  <-.001  .05 
Ethanol consumption (g/day)  .05                    -.01 
Education (years)  -.05                    -.04 
Metabolic syndrome, yes     .07*  .03** 
Smoking     
   Current, yes  -.02  .01 
   Past, yes   .02  .01 
Alcohol drinking, yes   .01                     -.01 
Hypertension, yes   .04  .02* 
Diabetes mellitus, yes  -.01  .05* 
Lipid lowering medication, yes   .06                    <.01 
***p <.001, **p<.01, *p<.05 
Pearson (r) or Spearman (rho) correlation coefficients for continuous variables; regression 
coefficients (β) for dichotomous or ordinal variables (two dummy variables for smoking were 
designed [current and past] and a p-value was obtained by using p-for-trend test) 
Abbreviation as Table 1. 
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 Table 16 Multivariate-adjusted mean of carotid IMT between Korean and Japanese men 
  Korean (n=102) Japanese (n=250)  
  Mean (SE) 95% CI Mean (SE) 95% CI P-value 
Crude  .655(.008) .640-.670 .616 (.005) .606-.625 <.0001 
Model I  .654 (.008) .638-.670 .616 (.005) .607-.626 <.0001 
Model II  .654 (.008) .638-.670 .616 (.005) .607-.626 <.0001 
Model III  .654 (.008) .638-.671 .616 (.005) .606-.626 <.0001 
Mean (SE), mean and standard error; IMT, intima-media thickness; CI, confidence interval 
Model I: adjusted for age, BMI, DBP, TC/HDL ratio, LDL-C, logTG, glucose, insulin, and pack-years 
of smoking 
Model II: further adjusted for metabolic syndrome and ethanol consumption  
Model III: further adjusted for education years, hypertension, diabetes, and use of lipid lowering 
medications 
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Figure 4 Distribution of carotid IMT scores by ethnicity 
 IMT=intima-media thickness  
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 3.1 ABSTRACT 
Objective: Different population groups have variability in habitual diet, especially in 
dietary polyunsaturated fatty acids (PUFA). Evaluating serum PUFA than dietary PUFA may be 
more robust for eliciting relations with lipoproteins. We aimed to identify relations between 
serum n-3/n-6 PUFA and lipoproteins in white, Japanese, and Japanese American men aged 40-
49. Methods and Results: We conducted a cross-sectional study in healthy 758 men by using a 
robust regression analysis. We analyzed serum PUFAs (% of total fat) by capillary-gas-liquid 
chromatography. After adjusting confounders, linoleic acid (LA) was significantly and inversely 
related to large very low-density lipoprotein particles (VLDL-p) and total LDL-p, and positively 
related to large high-density lipoprotein particles (HDL-p) across three population groups. LA 
had a consistent pattern of significant and inverse relationships with small LDL-p across three 
population groups (β = -40.6, -37.6, and -34.2 in white, Japanese, and Japanese American men, 
respectively). However, docosahexaenoic acid (DHA) had a population-specific pattern, showing 
significant and inverse relationships with small LDL-p only for whites (β = -108.2). 
Conclusions: LA was related to a favorable shifting of VLDL-p, LDL-p and HDL-p. DHA may 
influence the reduction of small LDL-p within a relatively moderate range of marine-derived n-3 
PUFA.  
 
Keywords: Lipoproteins; fatty acids/blood; fatty acids, Omega-3; fatty acids, Omega-6; 
population groups 
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 3.2 INTRODUCTION 
Atherogenic capabilities of lipoproteins may be determined by their particle concentration. 
Epidemiological studies demonstrated that concentrations of total low-density lipoprotein 
particles (LDL-p) and small LDL-p were predictors of clinical coronary heart disease (CHD)1-4 
and subclinical atherosclerosis,5 independent of LDL cholesterol (LDL-C). Large very low-
density lipoprotein particle concentration (VLDL-p) was also reported to be positively related to 
prevalence of subclinical atherosclerosis.6 On the other hand, large high-density lipoprotein 
particle concentration (HDL-p) was reported to be a protective factor against CHD events or 
progression.1, 7       
Blood (plasma or serum) proportions of polyunsaturated fatty acid (PUFA) may be 
markers for CHD risk. Epidemiological studies reported that circulating marine-derived n-3 
PUFAs, especially docosahexaenoic acid (DHA; 22:6n-3) with or without eicosapentaenoic acid 
(EPA; 20:5n-3), was inversely associated with fatal or non-fatal CHD events.8-11 Moreover, 
studies reported an inverse association of circulating linoleic acid (LA, 18:2n6) with non-fatal 
CHD events8 or cardiovascular mortality.12  
Some, but not all, clinical trials reported that enriched intakes of either dietary fish or fish 
oil supplement favorably influenced lipoproteins (e.g., large VLDL-p, small LDL-p [or LDL 
size] and large HDL-p).13-20 On the other hand, enriched LA diet has been well recognized to 
have a prominent effect of decreasing LDL-C.21 However, few clinical trials reported beneficial 
effects of LA on particle concentration or mean size of lipoproteins.18, 22 It is not clear that, in the 
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clinical trials, the outcomes of lipoprotein modification were the result from an enriched 
treatment diet or from exchanged proportions of other fatty acids (i.e. saturated fatty acids).18, 22 
Circulating PUFA (i.e. n-3 or n-6) is a biomarker of dietary PUFA intake.12, 23 Evaluating serum 
PUFA, rather than dietary PUFA assessed in most previous studies, may be more robust for 
eliciting relations with lipoprotein subclasses. 
Some evidence supports a different pattern of the relation between PUFA and coronary 
risk factors by population.24 Fish intake in the Japanese in Japan is one of the highest in the 
world, much higher than that in Americans.25, 26 No previous studies identified patterns of the 
relation between serum PUFA and lipoproteins in different population groups with considerable 
variability in marine-derived n-3 PUFA in habitual diet. Therefore, the purpose of the present 
study was to identify the relation between serum n-3 and n-6 PUFA and lipoprotein subclasses of 
VLDL, LDL and HDL, in the EBCT and Risk Factor Assessment among Japanese and U.S. 
Men in the Post World War II Birth Cohort (ERA-JUMP).27, 28 a population-based-cross-
sectional study of white, Japanese, and Japanese American men aged 40-49.  
 
3.3 METHODS 
3.3.1 Study population 
During 2002 to 2006, 926 men aged 40-49 were randomly selected: 310 Whites from Allegheny 
County, Pennsylvania, U.S., 313 Japanese from Shiga, Japan, and 303 Japanese Americans, 
Honolulu, Hawaii, U.S.28 All participants were without clinical cardiovascular disease, type 1 
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diabetes, or other severe diseases.27 Of the original sample, we excluded those (n=168) taking 
lipid-lowering medications and having type 2 diabetes and missing data. The final sample was 
758 men (white=261, Japanese=285 and Japanese American=212).  
Written informed consent was obtained from all participants. The study was approved by 
the Institutional Review Boards of the University of Pittsburgh, PA, U.S.; Shiga University of 
Medical Science in Otsu, Japan; and the Kuakini Medical Center, Honolulu, U.S. 
3.3.2 Nuclear Magnetic resonance (NMR) lipoprotein measurements 
Venipuncture was performed early in the clinic visit after a 12-hour fast. The samples were 
stored at -80°C and shipped on dry ice to the University of Pittsburgh.  
Using NMR spectroscopy at LipoScience, Inc (Raleigh, U.S.), lipoproteins of different 
size were quantified including VLDL, LDL, and HDL on serum.29, 30  Particle concentrations of 
the following lipoproteins were determined: 3 VLDL subclasses (large, >60nm; medium, 35-
60nm; and small, 27-35nm), 3 LDL subclasses (intermediate-density lipoprotein, 23-27nm; 
large, 21.3-23nm; small, 18.3-21.2nm), and 3 HDL subclasses (large, 8.8-13nm; medium, 8.2-
8.8nm; and small, 7.3-8.2nm).31 Weighted average particle sizes of VLDL, LDL, and HDL were 
calculated. 
3.3.3  Determination of serum fatty acids  
The fatty acid composition of serum lipids (i.e., phospholipids, triglycerides and cholesteryl 
esters) was determined by capillary-gas-liquid chromatography.32, 33 Coefficients of variation 
between runs for major PUFAs, EPA (20:5n-3), DHA (22:6n-3) and LA (18:2n-6), were 2.5%, 
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7.0% and 1.6%, respectively. Coefficients of variation for other major FAs: palmitic (16:0), 
stearic (18:0), oleic (18:1n-9), alpha-linolenic (ALA, 18:3n-3), arachidonic (AA, 20:4n-6), 
docosapentaenoic (DPA, 22:5n-3) acids, and total fatty acid amount were  1.2%, 4.0%, 2.3%, 
7.9%, 2.8%, 4.5%, and 5.7%, respectively.  
3.3.4 Physical and biochemical measurements 
The study protocol is described in detail elsewhere.27 Data collection was were standardized 
across three research sites. A self-administered questionnaire was used to obtain information on 
smoking, ethanol (g/day), and exercise.27 Exerciser was defined as those who do exercise more 
than three times per week.  
3.3.5 Statistical Analysis 
All fatty acids were analyzed as proportions (%) of total fatty acid amount (mg/dL). Marine-
derived n-3 PUFA was defined as a sum of EPA, DPA, and DHA; total n-3 PUFA as a sum of 
ALA and marine-derived n-3 PUFA; total n-6 PUFA as a sum of LA, 18:3n6, 20:2n6, 20:3n6, 
20:4n6 (AA), and 22:5n6. Saturated fatty acids were defined as a sum of 14:0, 16:0 and 18:0; 
monounsaturated fatty acids as a sum of 16:1n7, 18:1n7, and 18:1n9. 
To examine differences in lipoproteins and fatty acids by population, we performed an 
ANOVA test and Bonferroni test for multiple comparisons. We performed a robust regression 
analysis for each lipoprotein as a function of each fatty acid, after adjusting for covariates, 
including age, BMI, current smoking, ethanol consumption, glucose, insulin, trans fatty acids, 
and further adjusting for total n-6 or total n-3 PUFA according to each model. In the models 
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including marine-derived n-3, DHA or EPA as a primary predictor of interest, we placed total n-
6 PUFA; in the models including LA as a primary predictor of interest, we placed n-3 PUFA. To 
illustrate a population-specific association of each of DHA and LA with small LDL-p, we 
calculated a multivariable-adjusted mean of small LDL-p by a tertile group of either DHA or LA 
within each population group.  
Statistical significance was considered to be P<0.05. All statistical analyses were 
performed with STATA 9.0 for Windows (StataCorp LP, College Station, TX). 
3.4 RESULTS 
Our cohort had an average age of 45±3 years. The distribution of coronary risk factors across 
three population groups was reported in our previous studies.28  
 
3.4.1 Standard lipids and lipoprotein subclasses 
The white men had the highest level of LDL-C and the lowest level of HDL-C (Table 17). The 
Japanese men had the highest level of HDL-C. Total cholesterol and triglycerides did not differ 
significantly across three population groups. 
Overall the Japanese men had the most favorable features of VLDL-p and LDL-p (Table 
17). The Japanese men had the lowest levels of large VLDL-p and small VLDL-p, and the 
smallest size of VLDL-p. The white men showed the highest total LDL-p; Japanese American 
men showed the highest small LDL-p. The Japanese men had the most favorable features of 
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HDL subclasses: the highest large HDL-p and the largest HDL size. In contrast, white men had 
the lowest large HDL-p and the smallest size of HDL-p.  
The Japanese men had the highest levels of marine-derived n-3 (i.e., DHA+DPA+EPA) 
and its compositions (i.e., DHA and EPA) (Table 17). The Japanese men had more than 2 times 
higher marine-derived n-3 PUFA and DHA than white men. There was no significant difference 
in ALA across three population groups (0.3%, 0.4%, and 0.2% for white, Japanese and Japanese 
American men, respectively). The Japanese men had the lowest levels of total n-6 PUFA, LA 
and AA.  
3.4.2 Multivariable-adjusted models: Relations between fatty acids and lipoprotein 
subclasses 
Each of marine-derived n-3 (i.e., DHA+DPA+EPA; DHA; EPA) showed a consistent pattern of 
significant and inverse relationships with large VLDL-p and VLDL size across three population 
groups (Table 18). LA also held the same pattern. 
DHA and LA showed consistent patterns of significant and positive relationships with 
large HDL-p (Table 18) across three population groups. ALA showed a significant and positive 
relationship with large HDL-p only in the Japanese men; AA also held the same pattern as ALA.  
DHA showed significant and inverse relationships with total LDL-p and small LDL-p 
only in white men (Table 19). DHA, but not EPA, showed a significant relationship with total 
LDL-p. All the marine-derived n-3 and LA showed consistent patterns of significant and positive 
relationships with large LDL-p across three population groups. LA showed a consistent pattern 
of significant and inverse relationships with total LDL-p and small LDL-p across three 
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population groups. ALA had no significant relationships with any LDL-p. AA showed 
significant and inverse relationships with small LDL-p in the white and Japanese men. 
Figure 5 illustrated population-specific associations of DHA and LA with small LDL-p 
after adjusting for all the covariates using tertile groups of DHA and LA. DHA showed a 
negative and linear trend of the association with small LDL (p for trend=<0.001) among the 
white men, but not Japanese and Japanese American men.  LA showed consistent and negative 
trends of relationships with small LDL-p across three population groups (p for trend=<0.001, 
0.013, and 0.005 in white, Japanese, and Japanese American men, respectively).       
3.5 DISCUSSION 
We found that the serum levels of both LA and DHA had significant and inverse relationships 
with large VLDL-p (or size) and significant and positive relationships with large HDL-p (or size) 
in our cohort of white, Japanese, and Japanese American men aged 40 to 49. LA showed a 
consistent pattern of significant and inverse relationships with total LDL-p and small LDL-p 
across three population groups. DHA showed a population-specific pattern of significant and 
inverse relationships with total/small LDL-p (only in white men). 
Our findings on serum marine-derived n-3 PUFAs and large VLDL-p are in accordance 
with previous findings on enriched intakes of marine-derived n-3 PUFAs.16, 17 Some clinical 
trials reported that either dietary intake or fish oil supplementation decreased large VLDL-p.16, 17 
Large VLDL is positively correlated with plasma TG levels.34 Evidence shows a 
hypotriglyceridemic effect of marine derived n-3 PUFA,35 which may be related to our findings 
on marine-derived n-3 PUFA and large VLDL-p. On the other hand, very few studies reported 
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the effect of dietary LA on large VLDL-p.36 Our study supports a beneficial effect of dietary LA 
intake (e.g., safflower and sunflower oils) on large VLDL-p.   
We found that LA had inverse relationships with total and small LDL-p across three 
population groups. LA decreases LDL-C when it replaces either saturated fatty acids37, 38 or 
monounsaturated fatty acids.39.  An enriched LA diet has been reported in animal studies to 
increase hepatic LDL-receptor number.40 Hence, the inverse relationships between LA and LDL-
p in our findings may support this mechanism.  
The significant and inverse relationships between all the marine-derived n-3 and small 
LDL-p occurred only in white men. Consistently, intervention studies reported a decreasing 
effect of fish oil supplementation (DHA+EPA) on small LDL-p in Caucasians.13, 14, 19  One 
possible explanation of the population-specific pattern may be different levels of the marine-
derived n-3 PUFA across population groups. It was noted that the Japanese men had > 2 times 
higher levels of marine-derived n-3 PUFA than white men; Japanese American men also had 
higher than white men. It appeared that an intake of two fish meals per week was associated with 
reduction of small LDL-p in white men, and this corresponds to a serum level of marine n-3 of 5 
%. This intake has been recommended by several countries.35, 41 Higher intakes observed among 
either Japanese American or Japanese men may not provide additional benefit. At the same time, 
the population-specific pattern may be resulted from different levels in multivariable-adjusted 
small LDL-p across population groups. In figure 5, the Japanese and Japanese American men 
showed lower levels of multivariable-adjusted small LDL-p at the lowest tertiles of DHA (853.6 
nmol/L and 935.0 nmol/L, respectively) than white men (1,009.4 nmol/L). This may indicate that 
a long-term effect in habitual diet with relatively high intake of fish among the Japanese 
American and Japanese men might have produced a saturation of decreasing small LDL-p.    
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DHA, but not EPA, was inversely related to total LDL-p in white men, and positively 
related to large HDL-p across three population groups. DHA may have a stronger effect on 
lipoprotein modification. An meta-analysis reported that serum DHA is a stronger predictor of 
cardiovascular risk including both fatal and nonfatal events than serum EPA.8 Particularly, Mori 
et al. (2000) reported that a fish oil supplementation of DHA, compared to EPA, was effective on 
raising LDL size and increasing large HDL-p.15 However, we argue that the lack of association 
of EPA with total LDL-p may be in part attributed to a low proportion of EPA compared to DHA 
in circulating levels. Nevertheless, we assume that DHA may be dominant in decreasing total 
LDL-p and large HDL-p, compared to EPA.  
The serum levels of both DHA and LA were significantly and positively related to the 
level of large HDL-p. Otvos et al. (2002) demonstrated that large HDL-p contributed, to a large 
extent, to an increase in HDL-C, showing a fairly linear relationship.42, 43  Furthermore, there is 
evidence that fish oil supplementations increase large HDL-p, despite little effect on HDL-C.15, 19 
However, there have been no studies reporting on the beneficial effect of LA on large HDL-p, 
along with little evidence on its effect on HDL-C. Thus, our finding suggests that large HDL-p 
may have a favorable shifting by the effect of each of DHA and LA, regardless of its effects on 
HDL-C.   
The study has limitations. The study population of men aged 40-49 years limits the 
generalizability of the results to elderly and women groups. 
We found that higher serum levels of DHA and LA were related to beneficial 
modification of VLDL-p and HDL-p in a cohort of healthy white, Japanese, and Japanese 
American men aged 40-49. The present study supports an anti-atherogenic effect of LA through 
the modification of atherogenic lipoprotein profile. In addition, we suggest that marine-derived 
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n-3 PUFA may influence a reduction of total and small LDL-p within a relatively moderate 
range of serum levels. 
 
 
 
Table 17 Standard lipids, lipoprotein subclasses, and fatty acids across population groups in 2002-2006 (N=758) 
 
  Mean (SD) 
  U.S. white  (n=261)  Japanese (n=285)   Japanese American (n=212) 
Total cholesterol (mg/dl)  215.56 (2.3)  216.02 (2.1)    211.0 (36.0)  
LDL-C (mg/dl)  137.72 (2.1)  131.47 (2.1)    127.8 (33.0) b 
HDL-C (mg/dl)  48.43 (0.80)  54.21 (0.82) a   51.1 (12.3) c 
Triglycerides (mg/dl) a  125 (91-186)  134 (101-180)    136 (89-211)  
VLDL          
     Total VLDL-p (nmol/L)  93.0 (44.6)  90.3 (46.7)    107.7 (53.4) b c 
     Large VLDL-p (nmol/L) *  1.6 (0.6-5.8)  0.4 (0.1-2.8) a   1.8 (0.6-6.9) c 
     Small VLDL-p (nmol/L)  47.6 (21.4)  42.8 (24.2)    50.9 (24.1) c 
     VLDL size (nm)  49.8 (7.8)  43.9 (7.5) a   48.2 (6.7) c 
LDL          
    Total LDL-p (nmol/L)  1,478.0 (400.9)  1,381.8 (443.0) a   1,385.3 (514.2)  
    Large LDL-p (nmol/L)  533.2 (279.4)  511.5 (229.0)    343.1 (250.0) b c 
    Small LDL-p (nmol/L)*  813.0 (483.2-1,275.6)  806 (471-1,179)    992.1 (592.3-1,296.2) c 
    LDL size (nm)  21.0 (0.9)  21.1 (0.9)    20.6 (0.9) b c 
HDL          
    Total HDL-p (μmol/L)  31.3 (5.6)  35.2 (60.5) a   35.9 (5.9) b 
    Large HDL-p (μmol/L)  5.1 (3.2)  8.7 (4.1) a   6.2 (3.3) b c 
    Small HDL-p (μmol/L)  25.1 (4.5)  23.8 (5.6) a   26.8 (4.8) b c 
    HDL size (nm)  8.6 (0.5)  9.1 (0.5) a   8.8 (0.4) b c 
PUFA (%)  46.2 (4.5)  44.7 (3.8) a   47.7 (4.2) b c 
      DHA+DPA+EPA (%)  3.9 (1.8)  9.4 (3.0) a   5.0 (2.3) b c 
            DHA (%)  2.4 (1.3)  6.0 (1.7) a   3.3 (1.4) b c 
            EPA (%)  0.8 (0.6)  2.6 (1.5) a   1.1 (1.1) b c 
      Total n-6 (%)  41.9 (4.2)  35.0 (4.3) a   42.2 (4.0) c 
           LA (%)  30.1 (4.1)  26.4 (4.1) a   30.7 (4.2) c 
           AA (%)  8.9 (1.9)  6.6 (1.3) a   8.9 (2.2) c 
SFA (%)  31.0 (2.5)  31.7 (2.2)  a   30.7 (2.1) c 
MUFA (%)  20.1 (3.2)  21.2 (3.1)  a   18.9 (3.2) b c 
Trans fatty acids (%)  1.0 (0.5)  0.6 (0.2)  a   0.9 (0.4) b c 
* Values are expressed as median and inter-quartile range. SD=standard deviation; LDL-C=low density lipoprotein cholesterol; HDL-C=high density 
lipoprotein cholesterol; VLDL-p=very low-density lipoprotein particles; LDL-p=low-density lipoprotein particles; HDL-p=high-density lipoprotein particles; 
PUFA=polyunsaturated fatty acids; DHA=docosahexaenoic acid; DPA= docosapentaenoic acid; EPA=eicosapentaenoic acid; ALA=alpha-linolenic acid; 
LA=linoleic acid; AA=arachidonic acid; SFA=saturated fatty acids; MUFA=monounsaturated fatty acids 
 a : p<0.05 White versus Japanese, b: p<0.05 White versus Japanese American, c: p<0.05 Japanese versus Japanese American 
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Table 18 Relation of % PUFAs to VLDL and HDL subclasses in U.S. white (n=261), Japanese (n=285) and Japanese American men (n=212) 
 
 β coefficient 
 Large VLDL (nmol/L)  VLDL size (nm)  Large HDL (μmol/L)  Mean HDL size (nm) 
 W J JA  W J JA  W J JA  W J JA 
Model:  age + covariatesa +(total n-3 or total n-6) b  + trans fatty acids 
Marine-derived  n-3                
     DHA+DPA+ EPA -0.56* -0.16* -0.33*  -1.46* -1.80* -1.03*  0.37* 0.43* 0.17   0.45* 0.03*   0.00 
     DHA -0.67* -0.28* -0.46*  -1.87* -2.83* -1.45*  0.50* 0.54* 0.33†   0.06* 0.05*   0.01 
     EPA -1.51* -0.19* -0.70*  -4.00* -3.19* -2.10*  1.11* 0.89* 0.18  0.11† 0.04† -0.05 
Plant-derived n-3                 
    ALA 
n-6
  0.92 -0.42 -0.53*   0.66 -5.60† -1.43  -0.81 4.16* -0.81  -0.10 0.21 -0.00 
                
    LA -0.24* -0.09* -0.32*  -0.21† -0.94* -0.31*  0.18* 0.37* 0.12†  0.02* 0.03*  0.01† 
    AA -0.32* -0.05 -0.17†  -0.32 -1.20* -0.41†  0.15 0.70* 0.05    0.02 0.04†   0.00 
*p<0.01, †p<0.05     
 Abbreviation as Table 1. total n-3= DHA+DPA+EPA+ALA; total n-6 = sum of all n-6 compositions 
a Covariates indicate body mass index, current smoking, ethanol consumption, glucose, and  insulin. 
bMarine n-3, DHA, EPA and ALA were adjusted for total n-6; LA and AA were adjusted for total n-3.  
W, J and JA denote white men, Japanese men, and Japanese American men, respectively. 
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 β coefficient 
 Total LDL (nmol/L)  Large LDL (nmol/L)  Small LDL (nmol/L)  Mean LDL size (nm) 
 W J JA  W J JA  W J JA  W J JA 
Model:  age + covariates a + (total n-3 or total n-6) b  + trans fatty acids 
Marine-derived   n-3                
     DHA+DPA+EPA -20.43    11.13    5.03  38.61* 26.78*  15.91†    -65.83* -10.11   -5.83   0.14* 0.05*  0.02 
     DHA -46.46†    20.81   -1.85  56.81* 38.27*  26.38†  -108.15* -11.82 -18.86   0.22* 0.07†  0.06 
     EPA -15.48    18.11   17.47  83.59*   9.07*  29.68†  -123.16† -18.64   -4.13   0.30* 0.09*  0.04 
Plant-derived n-3                
    ALA 
n-6
  75.03 -142.42 -15.62    8.15 108.34 -65.29      82.67 258.85 -48.87  -0.15 0.53 -0.02 
                
    LA -29.25* -17.25† -25.62*  15.20* 22.74* 13.63*  -40.64* -37.57* -34.16*   0.07* 0.08*  0.06* 
   AA  10.79 -21.57  39.26*  43.00* 40.79*   7.12  -37.13* -62.16*   25.41  0.09* 0.13* -0.01 
*p<0.01, †p<0.05    Abbreviation as Table 1 and 2. 
Table 19 Relation of % PUFAs to LDL lipoprotein subclasses  in U.S. white (n=261), Japanese (n=285) and Japanese American men (n=212) 
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 Figure 5 Population-specific associations of DHA and LA with small LDL particles in multivariable-
adjusted models in white, Japanese and Japanese American men. 
Abbreviation as Table 1; Tertile groups of DHA and LA were placed into the models 
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3.6 SUPPLEMENT MATERIALS: ASSOCIATION BETWEEN SERUM PUFA AND 
FISH INTAKE 
3.6.1 Methods 
Frequency of fish intake was collected as more than once daily; every day; 4 to 5 times a 
week; 2 to 3 times a week; once a week; 1 to 3 times a month; less than once a month; rare or 
never. To examine associations between weekly fish intake and serum fatty acids, we performed 
a regression analysis for a specific fatty acid as a function of weekly fish intake as a continuous 
variable.  For this analysis, we collapsed the data of frequency of fish intake using different 
categories by population because of incomparable distributions between U.S. white and Japanese 
men. For white and Japanese American men, we collapsed into < once, once, and ≥ 2 times per 
week; for the Japanese men, ≤ once, ≥ 2 times, and ≥ 4 times. 
3.6.2 Summary of Results and Discussion 
       The proportions of marine-derived n-3 and its composition (i.e., DHA and EPA) 
were significantly associated with fish intake frequency (per week) across three population 
groups (Table 1). Among the Japanese men, total n-6 PUFA and LA were inversely associated 
with the frequency of fish intake (per week).  
       In our finding, the serum proportions of marine-derived n-3 PUFA reflected the 
dietary intakes of fish across three population groups. The Pearson correlation coefficients for 
DHA (r=0.37) and EPA (r=0.35) in white men were similar to those reported in the 
Atherosclerosis Risk in Community (ARIC) study (r=0.42 and r=0.23 for DHA and EPA, 
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respectively, measured by phospholipid in plasma).23 Because of lack of data, we were unable to 
observe correlations between serum LA and dietary LA. However, epidemiological studies 
demonstrated that dietary LA significantly correlated with serum LA proportion (r=0.50 in the 
Kuopio Ischemic Heart Disease Risk Factor study and r=.22 in the ARIC study).12, 23
Table 20 Associations between serum PUFA and dietary intake of fish within each population (N=758) 
 % by weight of total fatty acids, Mean (SD) 
Fish intake 
(per week) < Once Once  ≥ 2 times  ≥ 4 times 
P-value  
by fish intake 
U.S. white      
       Number 117 85 29   
       DHA+DPA+EPA   3.3 (1.3)   4.0 (1.6)   5.0 (2.1)  <0.001 
           DHA   2.0 (1.0)   2.5 (1.2)   3.1 (1.4)  <0.001 
           EPA   0.6 (0.3)   0.8 (0.6)   1.1 (0.7)  <0.001 
       Total n-6 42.4 (4.3) 41.3 (4.1) 41.9 (4.3)    0.279 
            LA 30.3 (4.2) 29.2 (3.8) 30.9 (4.2)    0.753 
Japanese      
       Number  45 121 119  
       DHA+DPA+EPA    7.8 (2.6)   8.7 (2.4 )   10.8 (3.1) <0.001 
           DHA    5.1 (1.5)   5.7 (1.6)   6.6 (1.6) <0.001 
           EPA    1.9 (1.2) 2.2 (.9)   3.2 (1.7) <0.001 
       Total n-6  36.8 (3.8) 35.8 (4.0) 33.4 (4.3) <0.001 
            LA  27.9 (3.9) 27.2 (3.8) 25.0 (4.1) <0.001 
Japanese American      
       Number 83 63 66   
       DHA+DPA+EPA   4.5 (2.0)   4.7 (1.9)   6.0 (2.8)  <0.001 
           DHA   2.9 (1.3)   3.1 (1.1)   3.9 (1.5)  <0.001 
           EPA   0.9 (0.8)   1.0 (0.9)   1.4 (1.4)    0.008 
       Total n-6 42.8 (3.7) 42.0 (3.9) 41.6 (4.4)    0.072 
            LA 31.2 (3.8) 30.5 (4.0) 30.2 (4.7)    0.123 
PUFA=polyunsaturated fatty acids; DHA=docosahexaenoic acid; DPA= docosapentaenoic acid; 
EPA=eicosapentaenoic acid; ALA=alpha-linolenic acid; LA=linoleic acid; AA=arachidonic acid; 
SFA=saturated fatty acids; MUFA=monounsaturated fatty acids; total n-3= DHA+DPA+EPA+ALA; total 
n-6 = sum of all n-6 compositions 
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4.1 ABSTRACT 
An assessment of segmental pulse wave velocity (PWV) allows for perspective on stiffening 
characteristics by type of the artery, i.e., central elastic artery vs. peripheral muscular artery. We 
aimed to examine correlations between segmental PWVs and to identify correlates of each 
segmental PWV with cardiovascular risk factors in a population-based sample of healthy white 
men aged 40 -49. We conducted a cross-sectional study in 248 men without diabetes, 
hypertension and cardiovascular disease. PWVs were simultaneously measured by an automated 
tonometry/plethysmogrphy system, heart-carotid (hc), heart-femoral (hf), carotid-femoral (cf), 
heart-brachial (hb), femoral-ankle (fa), and brachial-ankle (ba) PWVs.  cfPWV correlated 
strongly with hfPWV (r=0.87, p<0.001). baPWV correlated strongly with faPWV (r=0.68, 
p<0.001), followed by hfPWV (r=0.18, p=0.005). baPWV correlated partially with cfPWV 
(r=0.16, p=0.028) . In stepwise regression analyses, all the PWVs had a strong correlate of mean 
arterial pressure. The PWV of the central elastic arteries, e.g., hfPWV or cfPWV, had the 
correlates of age, body mass index, low-density lipoprotein cholesterol, and alcohol drinking. 
The PWV of the peripheral muscular arteries, i.e, faPWV, had the correlates of fasting insulin 
and smoking. baPWV had the correlates of fasting insulin and alcohol drinking. Among healthy 
middle-aged white men, baPWV correlated partially with cfPWV. baPWV showed a mixed 
characteristic of stiffness of the central and peripheral arteries. A primary independent correlate 
of PWV was mean arterial pressure across all the arterial segments. Other correlates of PWV 
differed by arterial segments. 
 
Key words: arterial stiffness; pulse wave velocity; aorta; arteries, carotid, brachial and femoral 
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4.2 INTRODUCTION 
Arterial stiffness is a predictor of the risk for cardiovascular disease in patients with 
hypertension1 as well as in the general population.2   Increased arterial stiffness is mainly related 
to aging process and high blood pressure and can be accelerated by cardiovascular risk factors.3-5   
Moreover, arterial stiffness is related to early atherosclerosis.6-8  
Arterial stiffness can be noninvasively evaluated by measuring pulse-wave velocity 
(PWV) through distance and time of traveling wave estimated by a specific segment of the 
arterial tree. Carotid-femoral PWV (cfPWV) measured by Doppler ultrasound is the most widely 
accepted index of aortic stiffness that has been considered a proxy for stiffness in other vessels. 
For this reason, cfPWV is recognized as a gold standard measure for evaluating arterial stiffness. 
Alternatively, brachial-ankle PWV (baPWV) measured by oscillometric/plethysmographic 
system has been recently paid attention, because of its high validity of aortic stiffness and 
practically simple methodology for large-scale population studies.9, 10  However, very few 
studies reported a correlation between cfPWV and baPWV using the same device system in 
apparently healthy adults.11 
An assessment of segmental PWVs allows for perspective on stiffening characteristics of 
arterial type determined by proximity from the heart (i.e. the central vs. the peripheral arteries), 
and the content of elastin and the number of smooth muscle cells (i.e., elastic vs. muscular 
arteries). The PWVs of arterial segments from the heart include heart-carotid PWV (hcPWV), 
heart-brachial PWV (hbPWV) and heart-femoral PWV (hfPWV). Technically, cfPWV may 
reflect the stiffness of the aorta, proximal aortic arteries and large arteries, while baPWV may 
reflect the stiffness of both central and peripheral arteries. Femoral-ankle PWV (faPWV) may 
entirely reflect the stiffness of the peripheral arteries, while hfPWV may entirely reflect the 
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stiffness of the aorta. An age-related increase in arterial stiffness may differ by the arterial type. 
The elastin-rich central arteries become stiffer with aging because of a decreased ratio of elastin 
to collagen contents with aging, which is probably related to elevated cfPWV.12-14 The elastin-
less peripheral arteries containing numerous smooth muscle cells may not be similarly influenced 
by aging.5  However, there is lack of evidence on segmental-specific relationships of arterial 
stiffness measured by PWV to other atherosclerotic or cardiovascular risk factors. 
We hypothesized that characteristics of arterial stiffness in relation to cardiovascular risk 
factors would differ by arterial segments. The objectives of the present study were twofold. First, 
we examined correlations among hcPWV, hfPWV, cfPWV, hbPWV, faPWV and baPWV 
(especially between cfPWV and baPWV) obtained simultaneously by using an automated 
oscillometric/tonometry system. Second, we identified correlates of each segmental PWV with 
cardiovascular risk factors and examined if the correlates differed by segmental PWVs. This 
study was conducted in a cohort of healthy white men aged 40 – 49 years of the EBCT and Risk 
Factor Assessment among Japanese and U.S. Men in the Post World War II Birth Cohort (ERA-
JUMP),  15-17 a population-based-cross-sectional study. 
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4.3 METHODS 
4.3.1 Study population 
During 2002 to 2006, 310 white men aged 40-49 were randomly selected from Allegheny 
County, Pennsylvania, U.S.18  All participants were without clinical cardiovascular disease, type 
1 diabetes, or other severe diseases.15  Of the original samples, we excluded 49 participants who 
had hypertension and type 2 diabetes and 9 participants who had having neither covariates nor 
parameters of PWV. Then 8 participants were further excluded having > 2,500 cm/sec of cfPWV 
because of measurement errors. 19 Our final sample was 248.  
Written informed consent was obtained from all participants. The study was approved by 
the Institutional Review Board of the University of Pittsburgh, Pittsburgh, PA, U.S. 
 
4.3.2 PWV measurement 
The PWV was automatically generated using a noninvasive and automated waveform analyzer 
(Colin-VP2000/1000, Omron, Japan/WaveNexus,TX). This device records the 
electrocardiography (ECG), phonocardiogram, and pressure waveforms; additionally measures 
arterial BP at the left and right brachial and ankles. ECG electrodes were placed on both wrists. 
A phonocardiogram was placed on the left edge of the 4th-rib-case; heart sounds S1 and S2 were 
detected. Pressure waveforms of the brachial and tibial arteries were recorded by a 
plethysmographic sensor and an oscillometric pressure sensor using the occlusion/sensing cuffs 
adapted to both arms (i.e., brachial arteries) and both ankles (i.e., tibial arteries). Pressure 
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waveforms of the carotid and femoral arteries were recorded using multiarray tonometry sensors 
placed at the left carotid and the left femoral arteries. Following 10 minutes of rest in a supine 
position, pressure waveforms were stored for a sampling time of 10 seconds with automatic gain 
analysis and quality adjustment. 
PWV (cm/second) was calculated as (path length between arterial sites) / (time interval). 
The path length for cfPWV was obtained by using the actual distance of participants’ body (in 
cm): ([cm from suprasternal notch to bottom of umbilicus] + [cm from botton of umbilicus to 
femoral sensor]) – [cm from carotid to suprasternal notch]. Also, the path length for heart-carotid 
(Dhc), the heart-brachial (Dhb), the heart-femoral (Dhf), the femoral-ankle (Dfa), and the 
brachial-ankle (Dfa – Dhb) segments on the basis of height (in cm) were obtained by using the 
following formulas: Dhc = 0.2437*HT-18.999; Dhb= 0.2195*HT -2.0734; Dhf =0.5643*HT-
18.381; and Dfa= 0.2486 *HT-30.709. Excellent reproducibility of the automated PWV 
measurement has been reported, with coefficients of variation of 6.0, 3.3, 4.9, and 3.3% for 
hcPWV, hbPWV, hf PWV, and faPWV, respectively.20 
  
4.3.3 Blood pressure measurement 
Blood pressure (BP) was simultaneously measured at the supine position by the oscillometric 
method of Colin-VP2000/1000 using the above cuffs at brachial arteries when PWV was 
measured. The standard brachial cuffs (No. 20 and 21) were used for participants whose arm 
circumference is 23 to 33 cm. For the study, we took systolic and diastolic BP derived from the 
average of the left and right brachial arteries. Mean arterial pressures were obtained from the 
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formula: (2*diastolic BP + systolic BP)/3. Pulse pressure was systolic BP subtracted by diastolic 
BP.   
4.3.4 Other measurement 
Venipuncture was performed early in the clinic visit after a 12-hour fast. The samples were 
stored at -80°C before their analysis. Biochemical markers (lipids, fasting insulin, and high 
sensitivity C-reactive protein [hs-CRP]) were described in detail elsewhere.15 A self-
administered questionnaire was used to obtain information on demography and smoking habits. 
Current smokers were defined as cigarette smokers over the last 30 days. Pack years of smoking 
were calculated as years of smoking multiplied by number of cigarettes per day smoked divided 
by 20. Alcohol drinking was defined as drinking more than twice per week. Exercise was defined 
as the regular exercise more than three times per week. Heart rate was measured after a 5-min 
rest by using an automated sphygmomanometer (BP-8800, Colin Medical Technology, Komaki, 
Japan).  
 
4.3.5  Statistical analysis 
Mean (standard deviation) and median (interquartile) are presented for basic characteristics of 
the study participants. To obtain correlation coefficients with adjustment for age and mean 
arterial pressure, we performed the partial correlation analysis between segmental PWVs. To 
examine univariate associations between each segmental PWV and cardiovascular risk factors, 
we used Spearman correlation analysis. To examine the determinants of each segmental PWV 
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(i.e., age, body mass index [BMI], MAP, heart rate, LDL-C, log-transformed triglycerides, high-
density lipoprotein cholesterol [HDL-C], glucose, log-transformed insulin, log-transformed hs-
CRP, pack-years of smoking, and exercise), we performed the stepwise regression analysis with 
backward removal (p <0.2) for variable selection, simultaneously using the robust regression for 
the satisfaction of underlying assumptions (i.e., normality and heteroscedasticity). Statistical 
significance was considered to be P<0.05. All statistical analyses were performed with STATA 
9.0 for Windows (StataCorp LP, College Station, TX). 
4.4 RESULTS 
Our cohort of white men had an average age of 45 years (Table 21). They were overweight at 
average. The average of blood pressure was 127/78 mmHg. Triglycerides and HDL-C were 
within normal limits; LDL-C was borderline high; Fasting glucose and insulin levels were within 
normal limits. Seven % of participants were current cigarette smokers, 45% were alcohol 
drinkers, and 54% were exercisers at three times or greater (per week).  
The PWV of the peripheral muscular artery, i.e., faPWV was higher than the PWVs of 
the central elastic arteries, i.e., hcPWV, hfPWV and cfPWV (Figure 6). baPWV showed the 
highest value; hbPWV showed the lowest value. hcPWV, hfPWV and cfPWV showed similar 
values. hcPWV, hfPWV, cfPWV and hbPWV showed right-skewed distributions, whereas 
baPWV and faPWV showed normal distributions. 
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4.4.1 Partial correlation between PWVs 
 cfPWV had a strong positive correlation with hfPWV (r=0.87, p<0.001), but had no significant 
correlation with faPWV (Table 22). baPWV had a strong positive correlation with faPWV 
(r=0.68, p<0.001), followed by hfPWV (r=0.18, p=0.005) and cfPWV (r=0.16, p=0.028) . 
hfPWV had a negative correlation with faPWV (r=-0.18, p<0.005). hcPWV had a positive 
correlation with hfPWV (r=0.28, p<0.001), but no significant correlation with faPWV. hbPWV 
had a positive  correlation with both hfPWV (r=0.25, p=0.015). hcPWV and hbPWV showed a 
modest positive correlation (r=0.47, p<0.001).    
4.4.2 Association between PWV and cardiovascular risk factors 
The univariate analyses showed that MAP correlated strongly with all the PWVs (Table 23).  
Age had significant positive correlations with the PWVs of arterial segments derived from the 
heart, i.e., hcPWV, hfPWV and hbPWV, but not with cfPWV, faPWV or baPWV. BMI and hs-
CRP had significant and positive correlations with the PWVs of the central arteries (hcPWV, 
hfPWV and cfPWV). Triglycerides and fasting insulin had significant and positive correlations 
with the PWVs of both central and peripheral arteries, i.e., hcPWV, hfPWV and cfPWV; faPWV 
and baPWV. HDL-C had significant and negative correlations with the PWVs of the central 
arteries (i.e., hfPWV and cfPWV). Heart rate had significant and positive correlations with 
cfPWV, faPWV and baPWV. Pack years of smoking had significant and positive associations 
with hbPWV and faPWV. Alcohol drinking had significant and negative associations with the 
PWVs of both central and peripheral arteries (i.e., hfPWV and cfPWV; faPWV and baPWV).  
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Multivariable-adjusted analyses showed that MAP had significant associations with 
PWVs across all the segments (Table 24), after adjusting age, BMI, heart rate, LDL-C, 
triglycerides, HDL-C, glucose, insulin, hs-CRP, smoking, alcohol drinking, and exercise. Age 
had significant associations with hfPWV, hcPWV and hbPWV. BMI was significantly and 
positively associated with hfPWV and cfPWV, but significantly and negatively associated with 
faPWV and hbPWV. Heart rate had a significant and positive association with baPWV. LDL-C 
had a significant and positive association with hfPWV. Fasting insulin levels and pack years of 
smoking had significant and positive associations with faPWV. hs-CRP levels had a significant 
and positive association with hcPWV. Alcohol drinking had significant and negative associations 
with hfPWV and cfPWV. 
cfPWV had common predictor variables with hfPWV (i.e.,  MAP, BMI, LDL-C, insulin, 
and alcohol drinking). baPWV had common predictor variables with faPWV (i.e., MAP, insulin, 
and BMI). Moreover, baPWV had common predictor variables with cfPWV and hfPWV (i.e., 
MAP and alcohol drinking).  
4.5 DISCUSSION 
We found that baPWV and cfPWV correlated partially, in a cohort of middle-aged white men 
without diabetes, hypertension and clinical cardiovascular disease. We also found that although 
MAP was a primary independent correlate of PWVs across all the arterial segments, other 
correlates of PWV differed by arterial segments. The PWV of the central elastic arteries, e.g., 
hfPWV, hcPWV or cfPWV, had the correlates of age, BMI, LDL-C, hs-CRP, and alcohol 
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drinking. The PWV of the peripheral muscular arteries, i.e, faPWV, had the correlates of fasting 
insulin and smoking. baPWV had the correlates of fasting insulin and alcohol drinking.  
Our finding that baPWV weakly correlated with cfPWV (r=0.16) is inconsistent with 
previous findings. In a previous finding, the correlation (r=0.76) was much stronger in 406 
Japanese healthy adults aged 18-76 years.11 The fairly different magnitude of the correlations 
may be attributable to different ranges of age between the two studies. Our cohort was a narrow 
range-aged group of 40 to 49 years. Given gradual loss of the elastic content in the 
aorta/proximal arteries with aging, variability in aortic stiffness may be minimal within our aged-
group. Therefore, our finding is of importance to select a PWV measure when conducting a 
study and to interpret study findings according to different distribution of age.  
baPWV might be explained by cardiovascular risk factors to a greater extent than 
cfPWV. It is of note that the total variance of baPWV (R2=0.30) in the regression model was 
greater than that of cfPWV (R2=0.15). In our data, baPWV reflected the stiffness of mixed 
arterial segments of the central and peripheral arteries. Compared to the central arteries, the 
peripheral arteries have been considered to be less clinically important, especially in the relation 
to diseases. Kimoto et al. reported that among cardiovascular factors, diabetes were significantly 
associated with hfPWV, but not with faPWV in 290 healthy and diabetic patients .20 However, no 
evidence demonstrated the associations of other diseases or their risk factors with the PWV of 
the peripheral arteries in apparently healthy individuals. Therefore, we suggest that 
characteristics of stiffness involving the peripheral arteries may also play a role in the 
progression of cardiovascular disease in apparently healthy men.  
The association of age with arterial stiffness differed by arterial segments.  As reported 
consistently in previous studies,5, 13 age was significantly associated with stiffness selectively 
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apparent in the aorta and proximal large elastic arteries, i.e., hfPWV and hcPWV, rather than the 
peripheral and muscular arteries, i.e., faPWV. Unlike previous findings,12 age showed a lack of 
the significant association with cfPWV. It may be due to small variability in cfPWV within one-
decade aged group.  
Alcohol drinking may be a correlate of the PWV of the central artery. cfPWV had a 
significant and inverse association with alcohol drinking (≥ twice per week), whereas baPWV 
had a similar trend of the association with alcohol drinking (p=0.088).  Sierksma et al. reported 
that moderate alcohol consumption had an inverse association with aortic PWV measured by 
cfPWV in 370 men aged 40-80 years.21 The Rotterdam Study reported a similar trend in men 
aged >5522 The trend of baPWV in our finding may be an expected finding because baPWV had 
a mixed characteristic of stiffness of the central and peripheral arteries.     
The association between BMI and PWVs may differ by arterial segments. Interestingly, 
our finding showed that increased BMI was inversely related to the peripheral arterial stiffness 
(i.e., faPWV and hbPWV). Increased BMI was reported to be a predictor of aortic stiffness 
measured by cfPWV in men, in some, but not all, epidemiological studies.3, 8, 23 Arterial stiffness 
may be related to distensibility and arterial diameter of the artery. Zebekakis PE et al. (2005) 
reported that BMI was related to increased diameter and decreased distensibility in peripheral 
arteries including both brachial and femoral arteries.23 Experimental studies elucidated the effect 
of obesity of increasing regional blood flow to adipose as well as non-adipose tissues.24 
Therefore, the inverse association between peripheral PWVs and BMI might be attributable to a 
greater effort of increasing diameters, by a compensating mechanism to minimize decreased 
distensibility.       
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Assuming that hfPWV indicates the stiffness of the aorta, we can assume cfPWV may 
indicate the stiffness of the aortic/proximal aortic large arteries. In this context, the strong 
correlation between cfPWV and hfPWV in our findings was expected, along with the common 
predictor variables (i.e., MAP, BMI and LDL-C).  
LDL-C was a predictor variable of hfPWV. There is little evidence on the ability of LDL-
C as a predictor of aortic stiffness measured by PWV in previous studies. However, a few 
clinical trials reported that statin therapy (i.e., simvastatin or atorvastatin) had a beneficial effect 
of decreasing aortic stiffness, suggesting that the improvement of aortic stiffness may be related 
to the reduction of LDL-C.25, 26  
We found that hs-CRP level was significantly associated with hcPWV of the proximal 
large and elastic arterial stiffness. hcPWV was partially correlated with hfPWV of aortic stiffness 
(r=0.28). Consistently, Yasmin et al. (2004) reported hs-CRP as a predictor of aortic PWV in a 
healthy population.27 Hence, we speculate that a higher level of hs-CRP in our cohort of healthy 
men may be related to stiffness in the carotid artery in which atherosclerosis may play a role 
frequently. 
Our data showed that fasting insulin levels were significantly and positively associated 
with faPWV.  It was reported that, among patients with diabetes, arterial stiffness was 
predominantly increased in the femoral arteries.28 Thus stiffness in the lower peripheral arteries 
might be the result of earlier deterioration from hyperinsulinemia than stiffness in the central 
arteries.  
We also noted a positive association between baPWV and heart rate. However, the 
significant association between cfPWV and heart rate attenuated after multivariable-adjustment. 
The Cardiovascular Heart Study reported that the strongest predictor of aortic stiffness measured 
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by cfPWV was heart rate in elderly men.8 Elevated heart rate is a predictor of cardiovascular 
morbidity and mortality.29, 30 Sympathetic overactivity induces fasting heart rates, which 
increases arterial wall stress and causes hyperinsulinemia and insulin resistance.30, 31 Those 
mechanical and functional factors may involve across entire arterial tree. Hence, in this middle-
aged group, the significant association between baPWV and heart rate may be reasonable, 
because baPWV consisted of combined properties of aortic and peripheral arteries. 
The present study includes the cross-sectional nature of study design, which cannot 
distinguish between cause and effect. Our study also limits generalizability to female, elderly or 
other racial/ethnic subgroups. With regard to measurement errors of cfPWV derived from our 
device system, the errors may have occurred while capturing pressure waveforms because of a 
characteristic of participants (e.g, obesity). In fact, there was a significant difference in BMI 
between those >2,500 cm/sec and those ≤ 2500 cm/sec of cfPWV. Additionally, heart rate was 
not obtained by hand, but by the automated BP machine. 
In conclusion, we found that, among healthy middle-aged white men, cfPWV correlated 
partially with baPWV. baPWV showed a mixed characteristic of stiffness of aortic and 
peripheral arteries. Each segmental PWV may provide information on vascular responses to 
cardiovascular risk factors according to the type of central elastic vs. peripheral muscular 
arteries. 
4.6 PERSPECTIVES 
We have shown for the first time that the correlates of PWV with cardiovascular risk factors 
differed by arterial segments. baPWV was a combined stiffness of the central and peripheral 
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arteries, explained by cardiovascular risk factors to a great extent. These findings indicate that 
baPWV may be another surrogate marker of arterial stiffness. A cross-sectional study reported 
that baPWV was a better correlate of subclinical cardiovascular disease than cfPWV.7 In this 
regard, baPWV may be a useful tool in screening a high risk group of cardiovascular disease. 
This may have important implications for the potential utility of baPWV measured by very 
simple methodology for clinical practice or large-scaled population-based epidemiological 
studies. 
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 Figure 6 Distribution of segmental pulse wave velocity 
                                  a Median; interquartile, and range 
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Table 21 Basic characteristics of the study participants (N=248) 
   Age, years 44.9 (2.8) 
   BMI, kg/m2 27.3 (3.9) 
   Height, cm 179.9 (6.8) 
   Systolic BP, mmHg 127.1 (11.0) 
   Diastolic BP, mmHg 77.8 (7.5) 
   MAP, mmHg 94.2 (8.3) 
   Pulse pressure, mmHg 49.3 (6.6) 
   Heart rate, beats/min 64.2 (9.4) 
   LDL-C, mg/dL 135.6 (33.4) 
   Triglycerides, mg/dL 122.5 (90.5 - 179.0) 
   HDL-C, mg/dL 48.5 (12.9) 
   Fasting glucose, mg/dL 99.2 (7.9) 
   Fasting insulin, μIU/dL 12.4 (10.2 - 17.0) 
   hs-CRP, mg/dL 0.9 (0.5, 1.7) 
   Current cigarette smoker, n (%) 18.0 (7.3) 
   Pack years of smoking, years 0.0 (0.0 - 1.1) 
   Alcohol drinking, n (%) 112 (45.2) 
   Exercise, n (%) 134 (54.0) 
Values are means (standard deviations) or median (interquartile) for continuous variables and total 
number (percentages) for categorical variables  
BMI = body mass index; BP = blood pressure; MAP=mean arterial pressure; LDL-C = low density 
lipoprotein cholesterol; HDL-C = high density lipoprotein cholesterol; hs-CRP = high sensitivity C-
reactive protein; Exercise was defined as regular exercise ≥ three times per week. 
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Table 22  Age- and MAP-adjusted correlationsa between segment-specific pulse wave velocity (n=248) 
 r 
Pulse wave velocity Heart-
carotid 
Heart-
femoral 
Carotid-
femoral 
Heart-
brachial 
Femoral-
ankle 
Brachial-
ankle 
     Heart-carotid   1.00      
     Heart-femoral   0.28*   1.00     
     Carotid-femoral  -0.02   0.88*   1.00    
     Heart-brachial   0.47*   0.16†   0.02 1.00   
     Femoral-ankle  -0.09 -0.19*  -0.10 0.23 1.00  
     Brachial-ankle  -0.01   0.18*   0.16† 0.15† 0.68* 1.00 
a Partial correlation was performed. 
*p<0.01, †p<0.05 
MAP=mean arterial pressure 
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Table 23 Univariate associationsa between pulse wave velocity and cardiovascular risk factors (N=248) 
 Pulse wave velocity 
 Heart- 
carotid 
Heart- 
femoral 
Carotid- 
femoral 
Heart-
brachial 
Femoral-
ankle 
Brachial-
ankle 
 Spearman rho 
   Age, years  0.19*   0.16†   0.03   0.24*   0.02   0.09 
   BMI, kg/m2  0.31*   0.27*   0.29*   0.03   0.00   0.12 
   Systolic BP, mmHg  0.42*   0.46*   0.40*   0.42*   0.34*   0.44* 
   Diastolic BP, mmHg  0.51*   0.45*   0.35*   0.53*   0.47*   0.48* 
   MAP, mmHg  0.50*   0.47*   0.38*   0.52*   0.44*   0.48* 
   Heart rate, beats/min  0.04   0.10   0.15† -0.06   0.23*   0.27* 
   LDL-C, mg/dL  0.05   0.08   0.06   0.05   0.00   0.05 
   Triglycerides, mg/dL  0.22*   0.18*   0.16†   0.03   0.14*   0.17* 
   HDL-C, mg/dL -0.11 -0.15† -0.16† -0.01   0.00 -0.04 
   Fasting glucose, mg/dL  0.11   0.08   0.15†   0.05   0.02   0.12 
   Fasting insulin, μIU/dL  0.23*   0.22*   0.27*   0.12   0.19§   0.22* 
   C-reactive protein, mg/dL  0.26*   0.16†   0.14†   0.06   0.09   0.08 
   Pack years of smoking, years  0.12   0.04   0.02   0.19*   0.18*   0.10 
   Alcohol drinker, n (%) -0.11 -0.19* -0.20§ -0.04 -0.13† -0.17* 
   Exercise, n (%) -0.04 -0.04 -0.14†   0.10 -0.16 -0.13† 
*p<0.01, †p<0.05 
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Table 24 Stepwise regression analysisa: Associations between pulse wave velocity and cardiovascular risk 
factors (N=248) 
 β p-value 95% CI R
2  β p-value 95% CI R
2 
Heart-carotid PWV    0.25 Heart-brachial PWV   0.37 
Age 13.58 0.001 (5.64, 21.52)  Age 4.80 0.000 (2.19, 7.41)  
MAP 8.99 0.000 (6.22, 11.75)  MAP 4.73 0.000 (3.75, 5.71)  
Heart rate -3.75 0.005 (-6.38, -1.12)  Heart rate -1.36 0.000 (-2.07, -0.65)  
Insulin 48.23 0.079 (-5.71, 102.17)  BMI -3.72 0.000 (-5.72, -1.71)  
hs-CRP 30.65 0.019 (5.01, 56.30)  Insulin 17.66 0.096 (-3.18, 38.50)  
      Smoking 1.10 0.020 (0.17, 2.02)  
      Exercise 18.49 0.011 (4.21, 32.76)  
            
Heart-femoral PWV    0.22 Femoral-ankle PWV   0.28 
Age 8.14 0.016 (1.55, 14.73)  Age -0.23 0.919 (-4.76, 4.30)  
MAP 6.87 0.000 (4.20, 9.54)  MAP 5.76 0.000 (4.05, 7.47)  
BMI 8.77 0.018 (1.49, 16.05)  BMI -6.98 0.000 
(-
10.63, -3.34) 
 
LDL-C 0.66 0.040 (0.03, 1.29)  Insulin 40.49 0.029 (4.26, 76.72)  
Insulin -32.53 0.197 (-82.11, 17.04)  Smoking 1.26 0.052 (-0.01, 2.54)  
Alcohol -70.77 0.001 (-111.45, -30.08)        
            
Carotid-femoral PWV   0.15 Brachial-ankle PWV   0.30 
Age 2.93 0.638 (-9.31, 15.16)  Age 3.04 0.322 (-3.00, 9.08)  
MAP 7.37 0.002 (2.64, 12.09)  MAP 8.07 0.000 (5.89, 10.25)  
BMI 19.70 0.001 (8.07, 31.33)  Heart rate 2.08 0.017 (0.37, 3.79)  
LDL-C 0.81 0.159 (-0.32, 1.93)  BMI -4.32 0.064 (-8.88, 0.25)  
Insulin -62.61 0.144 (-146.85, 21.64)  Insulin 32.09 0.161 (-12.87, 77.04)  
Smoking -2.26 0.155 (-5.37, 0.86)  Alcohol -25.95 0.088 (-55.82, 3.92)  
Alcohol -108.40 0.003 (-179.47, -37.33)        
MAP = mean arterial pressure; BMI = body mass index; LDL-C = low density lipoprotein cholesterol; HDL-C = high density 
lipoprotein cholesterol; hs-CRP = high sensitivity C-reactive protein; Smoking=pack years of smoking, Alcohol=drinker ≥2 times 
per week aThe stepwise regression was performed for backward removal (p <0.2). In each model, we placed age, MAP, BMI, 
heart rate, LDL-C, triglycerides, HDL-C, glucose, insulin, hs-CRP, pack-years of smoking, alcohol drinker, and exercise into 
models. Triglycerides, insulin, and C-reactive protein were log-transformed 
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5.0  DISCUSSION 
5.1 SIGNIFICANCE OF FINDINGS AND FUTURE RESEARCH 
The three articles demonstrated that: 1) Among middle-aged men, Koreans in South Korea had a 
significantly higher level of carotid IMT than the Japanese in Japan.109 2) Of polyunsaturated 
fatty acids, the proportion of DHA in serum was significantly and inversely associated with 
unfavorable levels of lipoprotein subclasses in white men; the proportion of LA in serum were 
significantly and inversely associated with unfavorable levels of lipoprotein subclasses in all 
three population groups of Japanese, Japanese American, and U.S. white men. 3) Associations 
between PWV and cardiovascular risk factors differed by arterial segments, i.e., the central 
elastic vs. the peripheral muscular arteries. Brachial-ankle PWV had a mixed characteristic of the 
stiffness of the central elastic and peripheral muscular arteries and shared common predictor 
variables with carotid-femoral PWV and heart-femoral PWV (i.e., the stiffness of the central 
elastic arteries) as well as with femoral-ankle PWV (i.e., the stiffness of the peripheral muscular 
arteries). 
The significantly higher level of carotid IMT in Korean men than Japanese men may 
indicate that middle-aged Korean men may continue to be at more increased risk for CHD than 
Japanese men at least over the near future. In addition, the observation may be in accordance 
with the fact from the vital statistics that Korean men have higher stroke mortality than the 
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Japanese men.110 Generally, the difference in risk for CHD by ethnicity can be explained by 
variation in the distribution of coronary risk factors.13 However, our finding showed that the 
distribution of coronary risk factors in Korean men was more favorable than or similar to those 
in Japanese men. Moreover, the coronary risk factors hardly explained the higher IMT in the 
Korean men than in the Japanese men. In this context, other factors than the factors examined in 
the study may be explaining factors for the difference in carotid IMT between the two population 
groups. Therefore, a study on the exploration of the explaining factors is needed, which can 
provide a preventive strategy for reducing the risk for CHD in South Korea.      
Differences in fat intake quality (e.g., marine-derived n-3 fatty acids) between two 
populations may differentiate the difference in carotid IMT. Koreans consume relatively less fish 
of 60g per day than the Japanese population who has been well known to uniquely have high fish 
consumption, 120g per day.111, 112 Hino et al. reported that n-3 fatty acids intakes (e.g. 
eicosapentaenoic acid or docosahexaenoic acid) in fish had an inverse association with carotid 
IMT.113 The ERA-JUMP study reported that the serum proportion of marine-derived n-3 fatty 
acids had an inverse association with carotid IMT.6 Thus, high fish consumption, rich in EPA 
and DHA, may be protective against carotid atherosclerosis, which might in part explain the 
higher carotid IMT in Koreans than the Japanese. Therefore, we need to examine if marine-
derived n-3 fatty acids are an explaining factor for the difference in carotid IMT between Korean 
and Japanese men in future research. 
Of polyunsaturated fatty acids, a higher proportion of LA, a primary index of n-6 PUFA 
was significantly and inversely associated with unfavorable levels of lipoprotein subclasses in all 
three population groups of Japanese, Japanese American, and U.S. white men. The significant 
associations were independent of all potential covariates and n-3 PUFA. Our finding indicates 
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that a higher proportion of serum linoleic acid have anti-atherogenic effect through the action of 
the modification of atherogenic lipoproteins. 
Very few clinical trials reported the effects of enriched LA diet on atherogenic 
lipoproteins. One study reported a significant effect of enriched LA diet on small LDL particle 
concentration compared to enriched stearic diet; the other study reported non-significant effects 
on small LDL and large HDL particle concentrations. However, it is unclear about whether the 
effects of enriched LA in those clinical trials were the result of the substitution of saturated fatty 
acids or other fatty acids (i.e., monounsaturated fatty acids, or n-3 fatty acids). Furthermore, it 
needs to examine in clinical trials that the compliance of enriched LA diet was achieved by using 
circulating levels because the circulating levels reflect the LA intake. Therefore, a well-
organized randomized clinical trial needs to clarify the effects of enriched LA diet on 
atherogenic lipoproteins in future research.     
Correlates of pulse wave velocity with cardiovascular risk factors differed according to 
arterial segments, i.e., central elastic vs. peripheral muscular arteries. The mean arterial pressure 
was a primary independent correlate of all the segmental PWVs. Age, body mass index, LDL-C, 
and alcohol drinking were associated with the PWVs of the segments of the central elastic 
arteries; fasting insulin was associated with the PWV of the segments of the peripheral muscular 
arteries. Fasting insulin and alcohol drinking were associated with the PWV of mixed segments 
of the central and peripheral arteries. Thus, this study highlights that carotid-femoral PWV and 
brachial-ankle PWV may be differentially influenced by pathology associated with 
cardiovascular risk factors in different arterial segments. Carotid-femoral PWV is a measure of 
the stiffness of aorta or proximal aortic arteries having central elastic properties, while brachial-
ankle PWV is a measure of stiffness of combination of central elastic and peripheral muscular 
 94 
arteries. In our findings, brachial-ankle PWV was more likely to be explained by cardiovascular 
risk factors than carotid-ankle PWV (R2=0.11 vs. R2=0.33). A cross-sectional study reported that 
brachial-ankle PWV was better correlate of early atherosclerosis (i.e., prevalence of coronary 
calcification) in postmenopausal women than carotid-femoral PWV. However, the study 
measured the two indices of arterial stiffness by using different methodologies and different 
devices. Therefore, future research needs to determine if brachial-ankle PWV is a better correlate 
of early atherosclerosis than carotid-femoral PWV in the same device. 
5.2 LIMITATIONS OF STUDY 
The ERA-JUMP study provided a proper cohort for the achievement of the three specific aims in 
the dissertation. However, the study has several limitations. First, a cross-sectional nature of 
study design has difficulty in inferring a causal relationship between predictor variables and 
outcome variables in each study. Second, the study population had a certain range of age group 
(i.e., 40-49 years) and only male population, which limited generalizability to elderly and female 
population groups. However, the selection of the population aged 40-49 may help provide a more 
important epidemiologic tool for predicting future coronary risk when comparing two population 
groups (i.e., Korean and Japanese men) who adopted westernization of lifestyle. 
The study on carotid IMT scores between Korean and Japanese men had a limitation on 
small sample size, especially in Korean men (n=102). Even though the characteristics of the 
Korean men in the distribution of CHD risk factors and carotid IMT scores were not much 
different from those in previous studies, our findings on associations between carotid IMT and 
CHD risk factors showed a weaker pattern for a few risk factors (i.e., systolic blood pressure, 
 95 
body mass index, or LDL-C) in Korean men compared to Japanese men. Additionally, the 
Korean and Japanese research sites used different ultrasonography machines (Titan (Sonosite) 
high-resolution ultrasound system with a 10.5-MHz linear array vs. Toshiba 140A scanner 
equipped with a 7.5-MHz linear array) for measuring carotid IMT. However, the difference 
between machines was no greater than the variation between sonographers when evaluating 
between-machine differences.  
The study on the associations between PWV and cardiovascular risk factors had a 
limitation on the inference of a causal relationship. We found that mean arterial pressure was 
primary independent correlate of all the segmental PWVs. However, it is uncertain from our 
study design whether higher mean arterial pressure is the result of higher PWV or the cause of 
higher PWV. This uncertainty holds for other cardiovascular risk factors. Additionally, the 
narrow range of the age group may limit the results of the study to elderly groups. We found that 
carotid-femoral PWV relatively weakly correlated with brachial-ankle PWV compared to 
findings in previous studies conducting more wide range of aged group.114 Therefore, future 
research needs to examine the age-specific correlations between the two PWVs, using general 
population.    
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6.0  APPLICATION TO PUBLIC HEALTH 
CVD is the leading cause of mortality worldwide, responsible for one-third of all deaths.1 In the 
U.S., age-adjusted mortality rates from CHD started to decline during the 1960s and decreased 
steadily from 1980 through 2002115; however, CHD remains the leading cause of death. In most 
Asian countries (e.g., Japan, Hong Kong, and Singapore), the CHD mortality rates showed an 
increasing trend until approximately 1970.116-122 Thereafter, it has shown a decline similar to that 
observed in Western countries including U.S., England and Wales. In South Korea, aged-
adjusted CHD mortality increased until 1990 and thereafter leveled off.18    
Age-adjusted mortality rates may reflect neither trends in CHD mortality in young and 
middle-aged adults, nor recent trends in CHD mortality. In fact, mortality rates from CHD 
among U.S. adults age 35 to 54 years decreased from 1980 until 2000, but slightly increased 
from 2000 until 2002.115 CHD mortality among Korean men age 35-44 years since the late 1980s 
showed a rapidly increasing trend.4 Higher carotid IMT in Korean men than in Japanese men 
(aged 40 to 49) is likely to reflect a recent trend of the risk for CHD or stroke in South Korea. In 
this regard, our findings of the first article have important implications for public health: 1) we 
can provide scientific information imperative to addressing a health-related problem (i.e., an 
increasing risk for CVD) in the prevention of CVD in South Korea. 2) we can address the 
necessity of efforts to set up a surveillance system for the incidence of CVD. In addition, 
according to the U.S. health statistics, leveled-off or slightly increasing trend in mortality rates 
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from CHD among young or middle aged adults may be in accordance with considerable 
increases in several risk factors, including obesity, diabetes and hypertension in younger 
adults.115 Since a major goal of epidemiology is to identify subgroups in the population who are 
at high risk for disease,123 a high-risk group of Korean middle-aged men may be those having 
obesity, diabetes, and hypertension among middle-aged men based on the U.S. statistics. 
Therefore, efforts on the modification of those unfavorable risk factors in the high risk group 
may serve as a potential strategy for reducing CHD risk in the future in South Korea.  
The quality of dietary fat, but not the quantity, matters. Many epidemiological and 
clinical studies delineated cardioprotective effects of n-3 and n-6 fatty acids, including 
antiarrhythmic, hypolipidemic, and antithrombotic effects.124 With regard to hypolipidemic 
effects, the n-3 fatty acids, especially EPA and DHA, are well-known as having 
hypotriglyceridemic effects. Instead, they were reported to slightly increase LDL-C.124, 125  
Several clinical trials confirmed the beneficial effects of EPA and DHA on small LDL particle 
concentration that is another feature for determining CHD risk. Our finding, the linear inverse 
trend of the association between DHA (or DHA+EPA+DPA) and total/small LDL particle 
concentration in U.S. white men, indicates that U.S. people can still benefit through increasing 
fish intake in the U.S. diet because they consume less than a suggested amount of EPA and DHA 
in a population level. Current mean estimated intake of marine-derived n-3 PUFA in the U.S. is 
≤ 0.1 % of total energy that is much lower than a recommended intake of 0.25% of total energy 
(0.55 g/day at 2000 kcal).38 Therefore, it is needed to promote an enriched diet in fish or fish oil 
supplements in the U.S in the purpose of lipoprotein modification. On the other hand, a primary 
index of n-6 PUFA, LA is the predominant dietary fatty acids regulating LDL-C metabolism 
when saturated fatty acids were replaced with LA. Our finding, the linear trend of the inverse 
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association between LA proportion and atherogenic lipoproteins (i.e., total/small LDL particles 
and large VLDL particles), indicates that, regardless of marine-derived n-3, a relative increase in 
LA proportion (%) of total fat to a decrease in saturated fatty acid proportion, can contribute to a 
reduction in atherogenic lipoproteins. In the U.S., a mean intake of LA is estimated to be 16 
g/day for adult men (corresponding to approximately 6.4% of total energy) that is close to the 
adequate intake level (17g/day for adult men), based on the U.S. Department of Agriculture’s 
Nationwide Food Consumption Survey.126 Therefore, the substitution of saturated fatty acids for 
enriched LA within a total energy should be continuously promoted in the U.S. diet as well as in 
Japanese diet, which can lead to the reduction in atherogenic lipoproteins.  
We have shown for the first time that the correlates of PWV with cardiovascular risk 
factors differed by arterial segments. baPWV was a combined stiffness of the central and 
peripheral arteries, explained by cardiovascular risk factors to a great extent. These findings 
indicate that baPWV may be another useful index of arterial stiffness. A cross-sectional study 
reported that baPWV was a better correlate of subclinical cardiovascular disease than cfPWV.91 
In this regard, baPWV may be a useful tool in screening a high risk group of cardiovascular 
disease. This may have important implications for the potential utility of baPWV measured by 
very simple methodology for clinical practice or large-scaled population-based epidemiological 
studies. 
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